Search
All Clinical Trials in Canada
A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
241 - 252 of 3905
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recruiting
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by blinded independent central review (BICR).
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by blinded independent central review (BICR). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock, Arkansas +219 locations
UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock, Arkansas
Highlands Oncology Group-Research Department ( Site 0062), Springdale, Arkansas
Beverly Hills Cancer Center ( Site 0070), Beverly Hills, California
The Angeles Clinic and Research Institute ( Site 0040), Los Angeles, California
The Angeles Clinic and Research Institute- A Cedars-Sinai Affiliate ( Site 0079), Los Angeles, California
San Francisco Oncology Associates ( Site 0066), San Francisco, California
Stamford Hospital ( Site 0083), Stamford, Connecticut
Mount Sinai Cancer Center ( Site 0038), Miami Beach, Florida
Mid Florida Hematology and Oncology Center ( Site 0018), Orange City, Florida
Emory University School of Medicine-Phase I ( Site 0056), Atlanta, Georgia
Northside Hospital ( Site 0055), Atlanta, Georgia
Centricity Research Columbus Cancer Center ( Site 0005), Columbus, Georgia
Lewis Cancer and Research Pavilion ( Site 0063), Savannah, Georgia
Archbold Cancer Center ( Site 0071), Thomasville, Georgia
Edward-Elmhurst Healthcare, Elmhurst Hospital-Nancy W. Knowles Cancer Center ( Site 0017), Elmhurst, Illinois
Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Center ( Site 0078), Naperville, Illinois
Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne, Indiana
Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette, Indiana
Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood, Kentucky
Our Lady of the Lake Physician Group-Medical Oncology ( Site 0080), Baton Rouge, Louisiana
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0027), Minneapolis, Minnesota
Mercy Research - David C. Pratt Cancer Center ( Site 0006), Saint Louis, Missouri
Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0037), Reno, Nevada
Atlantic Health Morristown Medical Center ( Site 0077), Morristown, New Jersey
Stony Brook University-Cancer Center ( Site 0054), Stony Brook, New York
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo, North Dakota
Oregon Health and Science University ( Site 0052), Portland, Oregon
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster, Pennsylvania
Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston, South Carolina
Sanford Cancer Center ( Site 0053), Sioux Falls, South Dakota
Avera Cancer Institute- Research ( Site 0090), Sioux Falls, South Dakota
University of Tennessee Medical Center Knoxville ( Site 0082), Knoxville, Tennessee
Millennium Research & Clinical Development ( Site 0039), Houston, Texas
Huntsman Cancer Institute ( Site 0042), Salt Lake City, Utah
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0213), Ciudad Autonoma de Buenos Aires, Buenos Aires
Hospital Británico de Buenos Aires-Oncology ( Site 0207), Ciudad autónoma de Buenos Aires, Buenos Aires
Sanatorio Británico-Clinical Oncology Department ( Site 0206), Rosario, Santa Fe
Sanatorio Parque ( Site 0205), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0202), Buenos Aires, Not set
Hospital Privado Universitario de Córdoba-Hematology and Oncology ( Site 0204), Cordoba, Not set
Westmead Hospital ( Site 0701), Westmead, New South Wales
The Prince Charles Hospital ( Site 0700), Brisbane, Queensland
Fiona Stanley Hospital-Medical Oncology ( Site 0705), Murdoch, Western Australia
Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 1402), Linz, Oberosterreich
Medizinische Universitaet Innsbruck-Department for Internal Medicine V ( Site 1403), Innsbruck, Tirol
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 1400), Wien, Not set
Antwerp University Hospital-Thoracic Oncology ( Site 1503), Edegem, Antwerpen
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 1502), Yvoir, Namur
VITAZ ( Site 1500), Sint-Niklaas, Oost-Vlaanderen
Liga Norte Riograndense Contra o Câncer ( Site 0301), Natal., Rio Grande Do Norte
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0303), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 0302), Porto Alegre, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 0319), Santa Cruz do Sul, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0304), Barretos, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0313), São José do Rio Preto, Sao Paulo
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0100), Greenfield Park, Quebec
St. Marys Hospital Center ( Site 0107), Montreal, Quebec
Centre Hospitalier de l'Université de Montréal ( Site 0104), Montréal, Quebec
FALP-UIDO ( Site 0401), Providencia, Region M. De Santiago
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0404), Santiago., Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0400), Santiago, Region M. De Santiago
ONCOCENTRO APYS-ACEREY ( Site 0410), Viña del Mar, Valparaiso
Beijing Cancer hospital-Thoracic Surgery department I ( Site 1301), Beijing, Beijing
Beijing Peking Union Medical College Hospital-Thoracic surgery department ( Site 1302), Beijing, Beijing
Peking University People's Hospital. ( Site 1300), Beijing, Beijing
Fujian Cancer Hospital-oncology department ( Site 1314), Fuzhou, Fujian
The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 1320), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Thoracic surgery department ( Site 1313), Guangzhou, Guangdong
Henan Cancer Hospital-henan cancer hospital ( Site 1316), Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technology-Thoracic Surgery ( Site 1306), Wuhan, Hubei
Hubei Cancer Hospital ( Site 1308), Wuhan, Hubei
Xiangya Hospital Central South University-Thoracic surgery ( Site 1311), Changsha, Hunan
Hunan Cancer Hospital ( Site 1312), Changsha, Hunan
Nanjing First Hospital ( Site 1310), Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University-Thoracic Surgery Department ( Site 1318), Suzhou, Jiangsu
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 1330), Nanchang, Jiangxi
The First Hospital of Jilin University ( Site 1324), Changchun, Jilin
The Second Affiliated Hospital of Air Force Medical University ( Site 1332), Xian, Shaanxi
Shandong Cancer Hospital ( Site 1321), Jinan, Shandong
Zhongshan Hospital Fudan University ( Site 1325), Shangai, Shanghai
Shanghai Pulmonary Hospital-Thoracic Surgery department ( Site 1304), Shanghai, Shanghai
Sichuan Cancer hospital. ( Site 1327), Chengdu, Sichuan
The Second People's Hospital of Neijiang ( Site 1322), Neijiang, Sichuan
Yunnan Province Cancer Hospital ( Site 1315), Kunming, Yunnan
The first Affiliated Hospital, Zhejiang University School of-Thoracic Cardiovascular Surgery Ward ( Site 1303), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 1309), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 1328), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province ( Site 1329), Linhai, Zhejiang
Ningbo No. 2 Hospital ( Site 1305), Ningbo, Zhejiang
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 1600), Brno, Brno-mesto
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1601), Ostrava, Ostrava Mesto
CHRU de Brest ( Site 1804), Brest, Finistere
CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 1801), Toulouse, Haute-Garonne
CHU Charles Nicolle ( Site 1803), Rouen, Haute-Normandie
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1805), Limoges, Haute-Vienne
Groupe hospitalier Paris saint Joseph. ( Site 1807), Paris, Ile-de-France
Clinique Teissier Groupe ( Site 1811), Valenciennes, Nord
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1810), Clermont-Ferrand, Puy-de-Dome
Hospices Civils de Lyon - Hopital Louis Pradel ( Site 1809), Bron, Rhone
HIA Sainte Anne ( Site 1800), Toulon, Var
Hôpital Tenon ( Site 1802), Paris, Not set
Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1914), Esslingen, Baden-Wurttemberg
Katholisches Klinikum Koblenz ( Site 1911), Koblenz, Rheinland-Pfalz
Krankenhaus Martha-Maria Halle-Dölau-Klinik für Innere Medizin II ( Site 1908), Halle, Sachsen-Anhalt
Universitätsklinikum Leipzig ( Site 1915), Leipzig, Sachsen
SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1900), Gera, Thuringen
Vivantes Hospital Spandau-Klinik für Innere Medizin, Hämatologie, Onkologie und Gastroenterologie- ( Site 1912), Berlin, Not set
Helios Klinikum Emil von Behring Berlin-Zehlendorf ( Site 1916), Berlin, Not set
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 2006), Patras, Achaia
251 Hellenic Air Force General Hospital ( Site 2003), Athens, Attiki
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 2000), Athens, Attiki
Athens Medical Center ( Site 2005), Athens, Attiki
Metaxa Cancer Hospital of Piraeus ( Site 2002), Piraeus, Attiki
University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 2001), Heraklion, Irakleio
University General Hospital of Larissa-Oncology Clinic ( Site 2004), Larissa, Thessalia
European Interbalkan Medical Center ( Site 2007), Thessaloniki, Not set
Queen Mary Hospital ( Site 3400), Hksar, Not set
Hong Kong United Oncology Centre ( Site 3403), Kowloon, Not set
Queen Elizabeth Hospital ( Site 3402), Yau Ma Tei, Not set
Rambam Health Care Campus-Oncology Division ( Site 2203), Haifa, Not set
Shaare Zedek Medical Center ( Site 2206), Jerusalem, Not set
Rabin Medical Center ( Site 2204), Petah Tikva, Not set
Sheba Medical Center ( Site 2200), Ramat Gan, Not set
Humanitas Istituto Clinico Catanese ( Site 2315), Misterbianco, Catania
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 2302), Meldola, Emilia-Romagna
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 2300), Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori-Oncologia ( Site 2301), Monza, Lombardia
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 2309), Rome, Roma
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 2307), Firenze, Toscana
Humanitas Gavazzeni-ONCOLOGY ( Site 2310), Bergamo, Not set
Ospedale San Martino ( Site 2313), Genova, Not set
Ospedale San Raffaele-Oncologia Medica ( Site 2311), Milano, Not set
Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 2312), Parma, Not set
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 2303), Pavia, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 2306), Roma, Not set
APSS- Presidio Ospedaliero S. Chiara ( Site 2304), Trento, Not set
National Hospital Organization Shikoku Cancer Center ( Site 1216), Matsuyama, Ehime
Hospital of the University of Occupational and Environmental Health, Japan ( Site 1217), Kitakyushu, Fukuoka
Kobe City Medical Center General Hospital ( Site 1213), Kobe, Hyogo
St. Marianna University Hospital ( Site 1207), Kawasaki, Kanagawa
Kanagawa Cancer Center ( Site 1206), Yokohama, Kanagawa
Kansai Medical University Hospital ( Site 1211), Hirakata, Osaka
Kindai University Hospital ( Site 1212), Osakasayama, Osaka
Saitama Prefectural Cancer Center ( Site 1201), Kitaadachi-gun, Saitama
Juntendo University Hospital ( Site 1204), Bunkyo-ku, Tokyo
Tokyo Medical University Hospital ( Site 1203), Shinjuku, Tokyo
National Hospital Organization Kyushu Cancer Center ( Site 1218), Fukuoka, Not set
Fukushima Medical University Hospital ( Site 1200), Fukushima, Not set
Hiroshima University Hospital ( Site 1215), Hiroshima, Not set
Niigata Cancer Center Hospital ( Site 1208), Niigata, Not set
Okayama University Hospital ( Site 1214), Okayama, Not set
Osaka International Cancer Institute ( Site 1210), Osaka, Not set
Nippon Medical School Hospital ( Site 1205), Tokyo, Not set
Chungbuk National University Hospital-Internal medicine ( Site 1000), Cheongju-si, Chungbuk
National Cancer Center-Lung Cancer Center ( Site 1002), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital-Medical Oncology ( Site 1003), Seongnam, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 1001), Suwon-si, Kyonggi-do
Keimyung University Dongsan Hospital CRC room 1 ( Site 1006), Daegu, Taegu-Kwangyokshi
Asan Medical Center-Lung Cancer Center ( Site 1005), Seoul, Not set
Samsung Medical Center-Division of Hematology/Oncology ( Site 1004), Seoul, Not set
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0506), Guadalajara, Jalisco
Centro de Investigacion Clinica de Oaxaca ( Site 0509), Oaxaca de Juarez, Oaxaca
Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0504), Chihuahua, Not set
Mediadvance Clinical ( Site 0502), Chihuahua, Not set
Oaxaca Site Management Organization S.C. ( Site 0507), Oaxaca, Not set
Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 3453), Breda, Noord-Brabant
Isala, locatie Zwolle-Poli Longziekten ( Site 3454), Zwolle, Overijssel
Meander Medisch Centrum-Researchbureau Longgeneeskunde ( Site 3458), Amersfoort, Utrecht
Erasmus Medisch Centrum ( Site 3452), Rotterdam, Zuid-Holland
University Medical Center Groningen ( Site 3459), Groningen, Not set
Sint Antonius Ziekenhuis ( Site 3455), Utrecht, Not set
Auckland City Hospital ( Site 0800), Auckland, Not set
Akershus Universitetssykehus ( Site 2501), Lørenskog, Akershus
Drammen Sykehus, Vestre Viken HF ( Site 2502), Drammen, Buskerud
Sykehuset Innlandet HF Gjøvik ( Site 2503), Gjøvik, Oppland
Oslo universitetssykehus HF. Radiumhospitalet ( Site 2504), Oslo, Not set
IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0604), Lima, Not set
Oncosalud ( Site 0602), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 0600), Lima, Not set
Instituto Neuro Cardiovascular de las Americas ( Site 0607), Lima, Not set
Hospital Nacional Edgardo Rebagliati Martins-medical oncology ( Site 0603), Lima, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2600), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2601), Przemysl, Podkarpackie
Bialostockie Centrum Onkologii ( Site 2604), Bialystok, Podlaskie
Uniwersyteckie Centrum Kliniczne ( Site 2610), Gdansk, Pomorskie
Szpital Specjalistyczny w Prabutach Spolka z o.o. ( Site 2613), Prabuty, Pomorskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2606), Olsztyn, Warminsko-mazurskie
Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2602), Poznan, Wielkopolskie
UNIDADE LOCAL DE SAUDE DE MATOSINHOS-Serviço de Oncologia ( Site 2705), Matosinhos, Porto
Instituto Portugês de Oncologia de Coimbra Francisco Gentil-Oncologia Médica ( Site 2704), Coimbra, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702), Porto, Not set
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L.. ( Site 2803), Bucharest, Bucuresti
Spitalul Universitar de Urgență Elias ( Site 2804), București, Bucuresti
Cardiomed SRL Cluj-Napoca-Medical Oncology ( Site 2801), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2802), Florești, Cluj
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2805), Craiova, Dolj
SC ONCO CARD SRL ( Site 2808), Brasov, Not set
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2901), L Hospitalet, Barcelona
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2905), Santiago de Compostela, La Coruna
Hospital Insular de Gran Canaria-Oncology ( Site 2903), Las Palmas de Gran Canaria, Las Palmas
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2902), Pozuelo de Alarcon, Madrid
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2900), Barcelona, Not set
Hospital Clinico San Carlos-Oncology Department ( Site 2904), Madrid, Not set
Kantonsspital Graubünden-Medizin ( Site 3006), Chur, Grisons
Kantonsspital Münsterlingen - Spital Thurgau AG ( Site 3005), Munsterlingen, Thurgau
CHUV (centre hospitalier universitaire vaudois) ( Site 3003), Lausanne, Vaud
HFR Fribourg - Hôpital Cantonal ( Site 3004), Fribourg, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 1105), Taipei City, Taipei
Tri-Service General Hospital ( Site 1100), Taipei City, Taipei
Taoyuan General Hospital ( Site 1106), Taoyuan City, Taoyuan
Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 1103), Kaohsiung, Not set
Taichung Veterans General Hospital-Chest ( Site 1101), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 1102), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 1104), Taipei, Not set
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 3106), Adana, Not set
Gulhane Egitim Arastirma Hastanesi-Onkoloji ( Site 3104), Ankara, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 3101), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 3110), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 3103), Ankara, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 3107), Istanbul, Not set
Conditions: Non Small Cell Lung Cancer
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
Recruiting
The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squamous non-small cell lung cancer (NSCLC). Participants in this study have NSCLC that has continued to progress on prior treatment with EGFR tyrosine kinase inhibitors (TKIs).
The primary hypotheses of this study are that sacituzumab tirumotecan is better than platinum-based doublet chemotherapy (pe... Read More
The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squamous non-small cell lung cancer (NSCLC). Participants in this study have NSCLC that has continued to progress on prior treatment with EGFR tyrosine kinase inhibitors (TKIs).
The primary hypotheses of this study are that sacituzumab tirumotecan is better than platinum-based doublet chemotherapy (pemetrexed and carboplatin) in regard to progression-free survival (PFS) and overall survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Kaiser Permanente - Oakland ( Site 0054), Oakland, California +151 locations
Kaiser Permanente - Oakland ( Site 0054), Oakland, California
Kaiser Permanente - Roseville ( Site 0055), Roseville, California
Kaiser Permanente - San Francisco ( Site 0056), San Francisco, California
Kaiser Permanente - Santa Clara ( Site 0057), Santa Clara, California
Kaiser Permanente-Kaiser Permanente ( Site 0036), Vallejo, California
Kaiser Permanente - Walnut Creek ( Site 0058), Walnut Creek, California
Mid Florida Hematology and Oncology Center ( Site 0005), Orange City, Florida
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003), Marietta, Georgia
University of Michigan ( Site 0009), Ann Arbor, Michigan
Cox Medical Center North - Cox Medical Center/ Hematology/Medical Oncology ( Site 0051), Springfield, Missouri
Astera Cancer Care ( Site 0032), East Brunswick, New Jersey
Stony Brook University-Cancer Center ( Site 0038), Stony Brook, New York
Sanford Fargo Medical Center ( Site 0028), Fargo, North Dakota
Sanford Cancer Center ( Site 0024), Sioux Falls, South Dakota
Millennium Research & Clinical Development ( Site 0035), Houston, Texas
Clinica Adventista Belgrano-Oncology ( Site 0315), Caba., Buenos Aires
Instituto Alexander Fleming ( Site 0307), Ciudad Autónoma de Buenos Aires, Buenos Aires
Hospital Británico de Buenos Aires-Oncology ( Site 0304), Ciudad autónoma de Buenos Aires, Caba
Centro Privado de RMI Río Cuarto S.A. II ( Site 0310), Río Cuarto, Cordoba
Instituto de Oncología de Rosario ( Site 0301), Rosario, Santa Fe
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0303), La Rioja, Not set
Cross Cancer Institute ( Site 0201), Edmonton, Alberta
Waterloo Regional Health Network (WRHN) ( Site 0207), Kitchener, Ontario
Princess Margaret Cancer Centre ( Site 0203), Toronto, Ontario
McGill University Health Centre ( Site 0204), Montréal, Quebec
Anhui Provincial Cancer Hospital ( Site 3132), Hefei, Anhui
Beijing Cancer hospital ( Site 3100), Beijing, Beijing
Beijing Peking Union Medical College Hospital-pneumology department ( Site 3107), Beijing, Beijing
Chongqing University Cancer Hospital-Medical Oncology ( Site 3128), Chongqing, Chongqing
Fujian Cancer Hospital ( Site 3124), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University ( Site 3125), XiaMen, Fujian
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 3102), Guangzhou, Guangdong
Guangxi Medical University Affiliated Tumor Hospital-Respiratory Oncology ( Site 3103), Nanning, Guangxi
Harbin Medical University Cancer Hospital ( Site 3109), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 3105), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology ( Site 3121), Wuhan, Hubei
Hubei Cancer Hospital ( Site 3122), Wuhan, Hubei
The Second Xiangya Hospital of Central South University-Oncology ( Site 3104), Changsha, Hunan
Nanjing Drum Tower Hospital JiangBei International Branch Hospital ( Site 3117), Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University-Respiratory Department ( Site 3118), Suzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University ( Site 3119), Nanchang, Jiangxi
The Second Affiliated Hospital of Xi'an Jiaotong University ( Site 3130), XI An, Shaanxi
Jinan Central Hospital ( Site 3113), Jinan, Shandong
Shandong Cancer Hospital ( Site 3112), Jinan, Shandong
Zhongshan Hospital of Fudan University ( Site 3133), Shanghai, Shanghai
Shanxi Cancer Hospital ( Site 3114), Taiyuan, Shanxi
West China Hospital, Sichuan University ( Site 3126), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 3127), Chengdu, Sichuan
The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3101), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-Medical Oncology ( Site 3106), Hangzhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University-Respiratory department ( Site 3120), Wenzhou, Zhejiang
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0601), Valledupar, Cesar
IMAT S.A.S ( Site 0602), Monteria, Cordoba
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0600), Bogota, Distrito Capital De Bogota
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0606), Bogota, Distrito Capital De Bogota
Oncologos del Occidente ( Site 0604), Pereira., Risaralda
Fundacion Valle del Lili- CIC-Oncology CIC ( Site 0605), Cali, Valle Del Cauca
Nouvel Hôpital Civil (NHC) ( Site 1302), Strasbourg, Alsace
Clinique Clairval ( Site 1306), Marseille, Bouches-du-Rhone
Gustave Roussy ( Site 1303), Villejuif, Ile-de-France
Hopitaux Universitaires Paris Centre-Hopital Cochin-Unité d'Oncologie Thoracique ( Site 1304), Paris, Not set
All India Institute of Medical Sciences-Department of medical oncology ( Site 3303), New Delhi, Delhi
Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3301), New Delhi, Delhi
Rajiv Gandhi Cancer Institute And Research Centre ( Site 3300), New Delhi, Delhi
Artemis hospital ( Site 3307), Gurugram, Haryana
Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute-Centre for cancer ( Site 3302), Mumbai, Maharashtra
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1803), Milano, Lombardia
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1800), Milan, Lombardia
Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1802), Bari, Puglia
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 1804), Firenze, Toscana
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1801), Roma, Not set
Fujita Health University Hospital ( Site 3409), Toyoake, Aichi
Ehime University Hospital ( Site 3411), Toon, Ehime
National Hospital Organization Kyushu Cancer Center ( Site 3401), Fukuoka,, Fukuoka
Gunma Prefectural Cancer Center ( Site 3413), Ota, Gunma
Kanazawa University Hospital ( Site 3402), Kanazawa, Ishikawa
St. Marianna University Hospital ( Site 3415), Kawasaki, Kanagawa
Kanagawa Cancer Center ( Site 3416), Yokohama, Kanagawa
Miyagi Cancer Center ( Site 3406), Natori, Miyagi
Kansai Medical University Hospital ( Site 3414), Hirakata, Osaka
Saitama Prefectural Cancer Center ( Site 3417), Kitaadachi-gun, Saitama
Shizuoka Cancer Center ( Site 3405), Sunto-gun, Shizuoka
National Cancer Center Hospital ( Site 3408), Chuo, Tokyo
Toho University Omori Medical Center ( Site 3407), Ota, Tokyo
Kyushu University Hospital ( Site 3400), Fukuoka, Not set
Hiroshima City Hiroshima Citizens Hospital ( Site 3419), Hiroshima, Not set
Niigata Cancer Center Hospital ( Site 3403), Niigata, Not set
Okayama University Hospital ( Site 3404), Okayama, Not set
Osaka International Cancer Institute ( Site 3410), Osaka, Not set
Osaka Metropolitan University Hospital ( Site 3412), Osaka, Not set
Chungbuk National University Hospital ( Site 3804), Cheongju-si, Chungbuk
National Cancer Center ( Site 3803), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital ( Site 3807), Seongnam, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital ( Site 3800), Suwon-si, Kyonggi-do
Ajou University Hospital ( Site 3813), Suwon, Kyonggi-do
Pusan National University Yangsan Hospital ( Site 3802), Pusan, Kyongsangnam-do
Pusan National University Hospital ( Site 3805), Busan, Pusan-Kwangyokshi
Keimyung University Dongsan Hospital CRC room 1 ( Site 3814), Daegu, Taegu-Kwangyokshi
Chungnam national university hospital ( Site 3806), Jung-gu, Taejon-Kwangyokshi
The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3812), Seoul, Not set
Asan Medical Center ( Site 3810), Seoul, Not set
Samsung Medical Center ( Site 3811), Seoul, Not set
Korea University Guro Hospital ( Site 3808), Seoul, Not set
University Malaya Medical Centre ( Site 3507), Lembah Pantai, Kuala Lumpur
National Cancer Institute-Radiotherapy and Oncology ( Site 3504), Putrajaya, Kuala Lumpur
Hospital Tengku Ampuan Afzan ( Site 3506), Kuantan, Pahang
Hospital Pulau Pinang-Oncology, radiotherapy and palliat ( Site 3501), George Town, Pulau Pinang
Sarawak General Hospital-Radiotherapy Unit ( Site 3508), Kuching, Sarawak
Arké SMO S.A. de C.V. ( Site 0706), Mexico, Distrito Federal
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0700), Guadalajara, Jalisco
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0705), Monterrey, Nuevo Leon
Centro de Investigacion Clinica de Oaxaca ( Site 0704), Oaxaca de Juarez, Oaxaca
Oaxaca Site Management Organization S.C. ( Site 0701), Oaxaca, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2003), Bydgoszcz, Kujawsko-pomorskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000), Warszawa, Mazowieckie
Bialostockie Centrum Onkologii ( Site 2010), Bialystok, Podlaskie
Narodowy Instytut Onkologii - Oddzial w Gliwicach-II Klinika Radioterapi i Chemioterapii ( Site 2002), Gliwice, Slaskie
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2321), LHospitalet de Llobregat, Barcelona
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2322), Santiago de compostela, La Coruna
Hospital Universitario Juan Ramon Jimenez-Oncología Medica ( Site 2323), Huelva, Not set
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2324), Sevilla, Not set
Karolinska Universitetssjukhuset Solna ( Site 2401), Stockholm, Stockholms Lan
National Cheng Kung University Hospital ( Site 3901), Tainan City, Tainan
Chi Mei Hospital - Liouying Branch ( Site 3909), Tainan City, Tainan
National Taiwan University Cancer Center (NTUCC) ( Site 3907), Taipei City, Taipei
Changhua Christian Hospital ( Site 3904), Changhua, Not set
National Taiwan University Hospital - Hsinchu branch ( Site 3900), Hsinchu, Not set
Chang Gung Memorial Hospital at Kaohsiung ( Site 3905), Kaohsiung, Not set
Far Eastern Memorial Hospital ( Site 3912), New Taipei, Not set
Taichung Veterans General Hospital-Chest ( Site 3910), Taichung, Not set
National Taiwan University Hospital-Oncology ( Site 3908), Taipei, Not set
Mackay Memorial Hospital-Chest Medicine ( Site 3902), Taipei, Not set
Taipei Medical University Hospital ( Site 3903), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch-Clinic of Chest Medicine ( Site 3911), Taoyuan, Not set
Maharaj Nakorn Chiang Mai Hospital ( Site 4005), Muang, Chiang Mai
Faculty of Medicine - Khon Kaen University ( Site 4002), Muang, Khon Kaen
Faculty of Medicine Siriraj Hospital ( Site 4004), Bangkok, Krung Thep Maha Nakhon
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 4006), Dusit, Krung Thep Maha Nakhon
Ramathibodi Hospital ( Site 4001), Ratchathewi, Krung Thep Maha Nakhon
Lampang Cancer Hospital ( Site 4000), Mueang Lampang, Lampang
Songklanagarind hospital ( Site 4003), HatYai, Songkhla
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2504), Adana, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2501), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 2505), Ankara, Not set
Ankara Bilkent Şehir Hastanesi ( Site 2500), Ankara, Not set
I.E.U. Medical Point Hastanesi-Oncology ( Site 2503), Izmir, Not set
Hanoi Oncology Hospital ( Site 4198), Hanoi, Ha Noi
K Hospital - National Cancer Hospital ( Site 4193), Hanoi, Ha Noi
National Lung Hospital-Oncology Department ( Site 4194), Hanoi, Ha Noi
Thong Nhat Hospital ( Site 4192), Tan Binh District, Ho Chi Minh
Cho Ray Hospital ( Site 4190), Ho Chi Minh, Not set
Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 4191), Ho Chi Minh, Not set
Conditions: Non-small Cell Lung Cancer (NSCLC)
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Recruiting
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS.
All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there is blinded independent central r... Read More
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS.
All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there is blinded independent central review (BICR)-verified progressive disease by Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130), Burbank, California +206 locations
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130), Burbank, California
Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132), Grand Junction, Colorado
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0106), Marietta, Georgia
The University of Louisville, James Graham Brown Cancer Center ( Site 0121), Louisville, Kentucky
New England Cancer Specialists ( Site 0143), Westbrook, Maine
University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144), Worcester, Massachusetts
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115), Minneapolis, Minnesota
Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg, Mississippi
Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0134), Reno, Nevada
University Hospitals Cleveland Medical Center ( Site 0119), Cleveland, Ohio
Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0117), Corvallis, Oregon
Oncology Consultants P.A. ( Site 0129), Houston, Texas
Instituto Alexander Fleming ( Site 0306), Ciudad Autónoma de Buenos Aires, Buenos Aires
Hospital Británico de Buenos Aires-Oncology ( Site 0304), Ciudad autónoma de Buenos Aires, Caba
Centro Privado de RMI Río Cuarto S.A. II ( Site 0310), Río Cuarto, Cordoba
Instituto de Oncología de Rosario ( Site 0301), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0300), Buenos Aires, Not set
Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3002), Port Macquarie, New South Wales
Westmead Hospital ( Site 3000), Westmead, New South Wales
Grampians Health-Medical Oncology ( Site 3001), Ballarat Central, Victoria
Northern Hospital ( Site 3003), Epping, Victoria
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0409), Porto Alegre, Rio Grande Do Sul
Clinica Viver ( Site 0400), Santa Maria, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0402), Barretos, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0406), São José do Rio Preto, Sao Paulo
Instituto Nacional de Câncer - INCA ( Site 0405), Rio de Janeiro, Not set
Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0401), Sao Paulo, Not set
William Osler Health System ( Site 0203), Brampton, Ontario
Trillium Health Partners - Credit Valley Hospital ( Site 0202), Mississauga, Ontario
McGill University Health Centre ( Site 0200), Montréal, Quebec
Clinica Universidad Catolica del Maule-Oncology ( Site 0501), Talca, Maule
Bradfordhill-Clinical Area ( Site 0507), Santiago., Region M. De Santiago
Orlandi Oncologia-Oncology ( Site 0504), Santiago, Region M. De Santiago
FALP-UIDO ( Site 0509), Santiago, Region M. De Santiago
Bradford Hill Norte ( Site 0516), Antofagasta, Not set
Second Affiliated hospital of Anhui Medical University ( Site 3133), Hefei, Anhui
Beijing Cancer hospital-intrathoratic deparmtment II ( Site 3101), Beijing, Beijing
Beijing Peking Union Medical College Hospital-pneumology department ( Site 3100), Beijing, Beijing
Fujian Provincial Cancer Hospital ( Site 3131), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 3107), Xiamen, Fujian
The First Affiliated Hospital of Guangzhou Medical University ( Site 3134), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 3108), Guangzhou, Guangdong
Affiliated Hospital of Guangdong Medical University ( Site 3123), Zhanjiang, Guangdong
The Second Hospital of Hebei Medical University ( Site 3135), Shijiazhuang, Hebei
Harbin Medical University Cancer Hospital-oncology of department ( Site 3132), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 3116), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology ( Site 3117), Wuhan, Hubei
Wuhan Union Hospital ( Site 3130), Wuhan, Hubei
Hubei Cancer Hospital ( Site 3106), Wuhan, Hubei
Xiangyang Central Hospital-oncology department ( Site 3136), Xiangyang, Hubei
The Second Xiangya Hospital of Central South University ( Site 3138), Changsha, Hunan
Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3113), Wuxi, Jiangsu
The Affiliated Hospital of Xuzhou Medical College ( Site 3112), Xuzhou, Jiangsu
The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 3127), Nanchang, Jiangxi
The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 3121), Nanchang, Jiangxi
Jiangxi Provincial Cancer Hospital ( Site 3143), Nanchang, Jiangxi
Jilin Province Tumor Hospital-oncology department ( Site 3126), Changchun, Jilin
Jinan Central Hospital-oncology department ( Site 3122), Jinan, Shandong
Shandong Cancer Hospital ( Site 3119), Jinan, Shandong
Shanghai Changhai Hospital ( Site 3125), Shanghai, Shanghai
West China Hospital, Sichuan University ( Site 3124), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 3105), Chengdu, Sichuan
The Second People's Hospital of Neijiang ( Site 3140), Neijiang, Sichuan
Yunnan Province Cancer Hospital ( Site 3139), Kunming, Yunnan
The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3111), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province-Respiratory ( Site 3114), Taizhou, Zhejiang
IMAT S.A.S ( Site 0602), Monteria, Cordoba
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0600), Bogota, Distrito Capital De Bogota
Oncologos del Occidente ( Site 0603), Pereira., Risaralda
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1103), Ostrava, Ostrava Mesto
Multiscan-Onkologicke a radiologicke centrum Multiscan Pardubice ( Site 1105), Pardubice, Pardubicky Kraj
Vseobecna fakultni nemocnice v Praze-Onkologicka klinika ( Site 1106), Praha, Praha 2
Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 1102), Olomouc, Not set
Regionshospitalet Gødstrup-Kræftklinikken ( Site 1204), Herning, Midtjylland
Aalborg Universitetshospital, Syd-Department of Oncology ( Site 1201), Aalborg, Nordjylland
Odense Universitetshospital ( Site 1200), Odense C, Syddanmark
Hôpital Saint Joseph-ONCOLOGY ( Site 1308), Marseille, Bouches-du-Rhone
Institut Régional du Cancer Montpellier-Medical Oncology ( Site 1309), Montpellier, Herault
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt-Unité d'oncologie thoracique et cutané ( Site 1303), Limoges, Limousin
Centre d'Oncologie de Gentilly ( Site 1301), Nancy, Meurthe-et-Moselle
Centre Hospitalier de la Côte Basque ( Site 1300), Bayonne, Pyrenees-Atlantiques
L HOPITAL NORD OUEST ( Site 1310), Gleize, Rhone
Clinique de l'Europe-Service de pneumologie ( Site 1304), Amiens, Somme
Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1305), Poitiers, Vienne
Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Medizinische Klinik V ( Site 1409), München, Bayern
Klinikum Bogenhausen-Klinik für Pneumologie und Onkologische Pneumologie ( Site 1406), München, Bayern
Klinikum Nürnberg Nord-5. Med. Klinik ( Site 1407), Nuremberg, Bayern
Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 1412), Marburg, Hessen
Medizinische Hochschule Hannover-Department of Pneumology ( Site 1411), Hannover, Niedersachsen
Bethanien Krankenhaus Moers ( Site 1400), Moers, Nordrhein-Westfalen
Universitätsklinikum Münster - Albert Schweitzer Campus-Medizinische Klinik A ( Site 1410), Münster, Nordrhein-Westfalen
Universitätsmedizin Johannes Gutenberg Universität Mainz-3. Medizinische Klinik und Poliklinik ( Site 1404), Mainz, Rheinland-Pfalz
LungenClinic Grosshansdorf-Onkologie ( Site 1401), Grosshansdorf, Schleswig-Holstein
SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1403), Gera, Thuringen
Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1402), Berlin, Not set
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1807), Meldola, Emilia-Romagna
P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1803), Udine, Friuli-Venezia Giulia
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1800), Milan, Lombardia
Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1804), Bari, Puglia
AOU Renato Dulbecco ( Site 1801), Catanzaro, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1806), Roma, Not set
Fujita Health University Hospital ( Site 3411), Toyoake, Aichi
Hirosaki University Hospital ( Site 3429), Hirosaki, Aomori
National Cancer Center Hospital East ( Site 3403), Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center ( Site 3415), Matsuyama, Ehime
National Hospital Organization Kyushu Cancer Center ( Site 3417), Fukuoka,, Fukuoka
Kurume University Hospital ( Site 3418), Kurume, Fukuoka
Gunma Prefectural Cancer Center ( Site 3402), Ota, Gunma
National Hospital Organization Himeji Medical Center ( Site 3426), Himeji, Hyogo
Iwate Medical University Hospital ( Site 3428), Shiwa-gun, Iwate
St. Marianna University Hospital ( Site 3421), Kawasaki, Kanagawa
Yokohama Municipal Citizen's Hospital ( Site 3425), Yokohama, Kanagawa
Kanagawa Cancer Center ( Site 3408), Yokohama, Kanagawa
Matsusaka Municipal Hospital ( Site 3422), Matsusaka, Mie
Tohoku University Hospital ( Site 3424), Sendai, Miyagi
Sendai Kousei Hospital ( Site 3400), Sendai, Miyagi
Kansai Medical University Hospital ( Site 3412), Hirakata, Osaka
Osaka Medical and Pharmaceutical University Hospital ( Site 3413), Takatsuki, Osaka
National Hospital Organization Ureshino Medical Center ( Site 3427), Ureshino, Saga
Niigata Cancer Center Hospital ( Site 3409), Niigata, Saitama
Shizuoka Cancer Center ( Site 3410), Suntogun, Shizuoka
Dokkyo Medical University Hospital ( Site 3401), Shimotsugagun, Tochigi
Tokyo Metropolitan Komagome Hospital ( Site 3405), Bunkyo, Tokyo
Cancer Institute Hospital of JFCR ( Site 3404), Koto, Tokyo
Toho University Omori Medical Center ( Site 3420), Ota, Tokyo
Tokyo Medical University Hospital ( Site 3407), Shinjuku, Tokyo
National Center for Global Health and Medicine ( Site 3406), Shinjuku, Tokyo
National Hospital Organization Yamaguchi Ube Medical Center ( Site 3423), Ube, Yamaguchi
National Hospital Organization Kyushu Medical Center ( Site 3416), Fukuoka, Not set
Saiseikai Kumamoto Hospital ( Site 3419), Kumamoto, Not set
Osaka International Cancer Institute ( Site 3414), Osaka, Not set
Chungbuk National University Hospital-Internal medicine ( Site 3804), Cheongju-si, Chungbuk
Wonju Severance Christian Hospital ( Site 3808), Wonju, Kang-won-do
National Cancer Center ( Site 3801), Goyang-si, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3800), Suwon-si, Kyonggi-do
Ajou University Hospital-Hematology-Oncology ( Site 3806), Suwon-si, Kyonggi-do
Keimyung University Dongsan Hospital CRC room 1 ( Site 3807), Daegu, Taegu-Kwangyokshi
Asan Medical Center-Lung Cancer Center ( Site 3805), Seoul, Not set
Samsung Medical Center-Division of Hematology/Oncology ( Site 3802), Seoul, Not set
Higiea Oncologia ( Site 0721), Mexico City, Distrito Federal
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0715), Guadalajara, Jalisco
Axis Heilsa S. de R.L. de C.V. ( Site 0719), Monterrey, Nuevo Leon
Centro de Atención e Investigación Cardiovascular del Potosí ( Site 0713), San Luis Potosí, San Luis Potosi
Oaxaca Site Management Organization S.C. ( Site 0718), Oaxaca, Not set
Clinica Integral Internacional de Oncología ( Site 0714), Puebla, Not set
Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 1901), Breda, Noord-Brabant
ETZ Elisabeth-Department of Pulmonary Diseases ( Site 1902), Tilburg, Noord-Brabant
Isala, locatie Zwolle-Poli Longziekten ( Site 1903), Zwolle, Overijssel
Clinica Vallesur - AUNA ( Site 0854), Arequipa, Ariqipa
Detecta Clínica ( Site 0853), Surquillo, Muni Metro De Lima
IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0851), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0850), Lima, Not set
Hospital Cayetano Heredia-Oncology ( Site 0855), Lima, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2003), Bydgoszcz, Kujawsko-pomorskie
Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 2013), Grudziadz, Kujawsko-pomorskie
Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 2016), Torun, Kujawsko-pomorskie
SPZOZ Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej UM W Łodzi Centralny Szpital ( Site 2012), Łódź, Lodzkie
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 2015), Kraków, Malopolskie
Instytut Gruźlicy i Chorób Płuc w Warszawie-3rd Dep of Lung Diseases and Oncology ( Site 2011), Warszawa, Mazowieckie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001), Przemysl, Podkarpackie
Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 2104), Lisbon, Lisboa
Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2101), Lisbon, Lisboa
Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 2103), Vila Nova de Gaia, Porto
Hospital Dr. Nélio Mendonça ( Site 2105), Funchal, Regiao Autonoma Da Madeira
Hospital CUF - Tejo ( Site 2100), Lisboa, Not set
Hospital Jerez de la Frontera-UGC Oncología ( Site 2333), Jerez de la Frontera, Cadiz
CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2335), A Coruña, La Coruna
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2331), Pozuelo de Alarcon, Madrid
H.R.U Malaga - Hospital General ( Site 2332), Málaga, Malaga
Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2336), Valencia, Valenciana, Comunitat
Hospital Universitari Vall d'Hebron-Oncology ( Site 2330), Barcelona, Not set
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2337), Sevilla, Not set
Chi Mei Hospital - Liouying Branch ( Site 3908), Tainan City, Tainan
National Taiwan University Cancer Center (NTUCC) ( Site 3907), Taipei City, Taipei
National Taiwan University Hospital - Hsinchu branch ( Site 3901), Hsinchu, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3904), Kaohsiung, Not set
Chang Gung Memorial Hospital at Kaohsiung ( Site 3902), Kaohsiung, Not set
Taichung Veterans General Hospital-Chest ( Site 3905), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 3903), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 3906), Taipei, Not set
Chulalongkorn University-Medicine ( Site 4003), Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital ( Site 4000), Bangkok, Krung Thep Maha Nakhon
Maharaj Nakorn Chiang Mai Hospital-Chiang Mai Clinical Trial Unit (CM-CTU) ( Site 4001), Chiang Mai, Not set
Medipol Mega Universite Hastanesi-oncology ( Site 2508), Stanbul, Istanbul
Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2503), Bornova, Izmir
Erciyes University ( Site 2511), Talas, Kayseri
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2507), Adana, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2501), Ankara, Not set
Ultramar Imaging Center ( Site 2506), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 2505), Ankara, Not set
Ankara Bilkent Şehir Hastanesi ( Site 2500), Ankara, Not set
Pamukkale University Medical Faculty, Fahri Goksin Oncology Centre-Oncolgyy-Hematology ( Site 2510), Denizli, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2502), Istanbul, Not set
Ondokuz Mayıs Universitesi ( Site 2509), Samsun, Not set
Royal Free Hospital ( Site 2601), London, England
Queen Alexandra Hospital-Oncology Department ( Site 2603), Portsmouth, Hampshire
Kent and Canterbury Hospital-Oncology Research ( Site 2606), Canterbury, Kent
Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 2605), London, London, City Of
James Cook University Hospital ( Site 2604), Central Middlesbrough, Middlesbrough
K Hospital - National Cancer Hospital ( Site 4174), Hanoi, Ha Noi
National Lung Hospital-Oncology Department ( Site 4175), Hanoi, Ha Noi
Tam Anh General Hospital ( Site 4179), Hanoi, Ha Noi
Thong Nhat Hospital ( Site 4170), HCM, Ho Chi Minh
Cho Ray Hospital ( Site 4171), Ho Chi Minh, Not set
Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 4173), Ho Chi Minh, Not set
Conditions: Non-small Cell Lung Cancer (NSCLC)
Platform of Randomized Adaptive Clinical Trials in Critical Illness
Recruiting
PRACTICAL:
PRACTICAL is a randomized multifactorial adaptive platform trial for acute hypoxemic respiratory failure (AHRF). This platform trial will evaluate novel interventions for patients with AHRF across a range of severity states (i.e., not intubated, intubated with lower or higher respiratory system elastance, requiring extracorporeal life support) and across a range of investigational phases (i.e., preliminary mechanistic trials, full-scale clinical trials).
EXPAND-ECLS domain :
The EX... Read More
PRACTICAL:
PRACTICAL is a randomized multifactorial adaptive platform trial for acute hypoxemic respiratory failure (AHRF). This platform trial will evaluate novel interventions for patients with AHRF across a range of severity states (i.e., not intubated, intubated with lower or higher respiratory system elastance, requiring extracorporeal life support) and across a range of investigational phases (i.e., preliminary mechanistic trials, full-scale clinical trials).
EXPAND-ECLS domain :
The EXPAND-ECLS pilot trial is a multi-center, randomized, open-label, feasibility trial, embedded as a domain within the PRACTICAL platform trial. The ULTIMATE arm of this domain will evaluate the effect of ultra-low intensity ventilation facilitated by CO2 removal through VV-ECMO versus best current conventional ventilation on all-cause hospital mortality among patients with early moderate-severe AHRF with high respiratory system elastance receiving potentially injurious mechanical ventilation. The PROACTIVE arm of this domain will evaluate the effect of ECMO-facilitated strategy of earlier awakening, extubation, and rehabilitation versus best current conventional ventilation on all-cause hospital mortality among patients with early moderate-severe AHRF with high respiratory system elastance receiving potentially injurious mechanical ventilation.
Invasive Mechanical Ventilation (IMV) Strategies domain:
The IMV Strategies domain will evaluate multiple novel invasive ventilation strategies in comparison to conventional lung-protective ventilation in patients with acute hypoxemic respiratory failure (AHRF). Multiple approaches to mechanical ventilation are used, and the optimal approach is unknown. An efficient strategy to identify the best strategy is to compare multiple potential approaches simultaneously to determine more rapidly (a) which interventions are least effective (and should be dropped), and (b) which interventions result in the best outcomes for patients. In the current domain design, we will compare the current recommended ventilation strategy to two new approaches: a strategy that targets lung-inflating (driving) pressure instead of lung-inflating (tidal) volume, and a strategy that aims to maintain an optimal level of breathing effort to prevent diaphragm atrophy and injury while maintaining safe lung-inflating pressures.
CORT-E2 domain:
The Corticosteroid Early and Extended (CORT-E2) Trial is a phase III, multicentre Bayesian randomized controlled trial (RCT), which includes two cohorts within the domain; one examining the role of early corticosteroids as compared to not extending in persisting AHRF due to COVID or non-COVID (Extended Cohort).
FLUDRO domain:
The Fludrocortisone in Acute Hypoxemic Respiratory Failure with Airspace Disease (FLUDRO-1) domain is a phase II I trial. The trial aims to provide direct clinical evidence to resolve a critical long-standing question regarding the use of steroids in the treatment of AHRF with airspace disease.
FAST-3:
The Nebulized Furosemide for the Treatment of Pulmonary Inflammation in Patients with Respiratory Failure Secondary to Pulmonary Infection domain is a phase III trial. It aims to use nebulized furosemide as supportive therapy to improve Advanced Respiratory Support (ARS) free days up to day 28 in critically ill patients with AHRF.
IMV-ECLS:
The Invasive Mechanical Ventilation Strategies in Venovenous-Extracorporeal Life Support (PRESSURE; Positive Pressure to Maintain Lung Recruitment during Extracorporeal Life Support for Acute Hypoxemic Respiratory failure) is a pilot and feasibility trial. It aims to identify which positive end-expiratory pressure (PEEP) strategies improve lung function in patients with AHRF supported by ECLS. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: University Health Network, Toronto, Not set
University Health Network, Toronto, Not set
Conditions: Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Recruiting
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building... Read More
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building plans (genes) for this protein in cancer cells leads to a production of abnormal HER2 and therefore abnormal cell growth and division.
The study treatment, BAY 2927088, is expected to block the mutated HER2 protein which may stop the spread of NSCLC.
The main purpose of this study is to learn how well BAY 2927088 works and how safe it is compared with standard treatment, in participants who have advanced NSCLC with specific genetic changes called HER2 mutations.
The study participants will receive one of the study treatments:
* BAY 2927088 twice every day as a tablet by mouth, or
* Standard treatment in cycles of 21 days via infusion ("drip") into the vein. The treatment will continue for as long as participants benefit from it without any severe side effects or until they or their doctor decide to stop the treatment.
During the study, the doctors and their study team will:
* take imaging scans, including CT, PET, MRI, and X-rays, of different parts of the body to study the spread of cancer
* check the overall health of the participants by performing tests such as blood and urine tests, and checking
* heart health using an electrocardiogram (ECG)
* perform pregnancy tests for women
* ask the participants questions about how they are feeling and what adverse events they are having.
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Patty & George Hoag Cancer Center, Newport Beach, California +278 locations
Patty & George Hoag Cancer Center, Newport Beach, California
UC San Diego Health - Moores Cancer Center, San Diego, California
UCSF Bakar Precision Cancer Medicine Building - Thoracic Surgery and Oncology, San Francisco, California
UCLA Health Santa Monica Cancer Care, Santa Monica, California
The Oncology Institute of Hope and Innovation - Fort Lauderdale 17th Street, Fort Lauderdale, Florida
Memorial Cancer Institute at Miramar, Miramar, Florida
AdventHealth Cancer Institute, Orlando, Florida
Moffitt Cancer Center - Magnolia Campus, Tampa, Florida
Moffitt Cancer Center, Tampa, Florida
Piedmont Cancer Institute - Atlanta, Atlanta, Georgia
John B. Amos Cancer Center, Columbus, Georgia
University of Illinois Hospital - Outpatient Cancer Care Center, Chicago, Illinois
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology, Chicago, Illinois
UM Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
UMass Memorial Medical Center - University Campus - Oncology, Worcester, Massachusetts
Profound Research -OMG - TriAtria Cancer Center, Farmington Hills, Michigan
Profound Research - OMG - Royal Oak Cancer Center, Royal Oak, Michigan
University of Minnesota Medical Center, Minneapolis, Minnesota
R.J. Zuckerberg Cancer Center, New Hyde Park, New York
UC Medical Center - Oncology, Cincinnati, Ohio
Providence Cancer Institute - Franz Clinic, Portland, Oregon
Providence Oncology and Hematology Care Clinic Westside, Portland, Oregon
Allegheny General Hospital, Pittsburgh, Pennsylvania
UT Southwestern, Dallas, Texas
University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas
Virginia Commonwealth University, Richmond, Virginia
Fundación Cenit para la Investigación en Neurociencias, Caba, Ciudad Auton. De Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires, Not set
Centro de Educacion Medica e Investigaciones Clinicas "Norberto Quirno" (CEMIC), Buenos Aires, Not set
Centro Médico Privado CEMAIC, Córdoba, Not set
Instituto Argentino de Diagnostico y Tratamiento (IADT), TBC, Not set
Centro de Investigaciones Clínicas, Clínica Viedma, Viedma, Not set
Blacktown Cancer & Haematology Centre, Blacktown, New South Wales
Concord Repatriation General Hospital - Medical Oncology Clinical Trials Unit, Concord, New South Wales
Calvary Mater Hospital Newcastle, Waratah, New South Wales
University of the Sunshine Coast, Buderim, Not set
The Canberra Hospital (TCH) - Canberra Region Cancer Centre (CRCC), Garran, Not set
Austin Hospital - Olivia Newton John Cancer Research Institute, Heidelberg, Not set
Uniklinikum Salzburg, Universitätsklinik für Innere Medizin III, Salzburg, Not set
Uniklinikum Salzburg, Universitätsklinik für Pneumologie/ Lungenheilkunde, Salzburg, Not set
Medizinische Universität Wien Universitätsklinik f. Innere Medizin I Klinische Abteilung für Onkologie, Wien, Not set
Klinik Floridsdorf, Pneumo-onkologische Ambulanz und Tagesklinik, Wien, Not set
UZ Leuven Gasthuisberg - Pneumology Department, Leuven, Vlaams-Brabant
AZ Delta | Clinical Trial Center - Pneumology, Roeselare, West-Flanders
Antwerp University Hospital | Oncology Department, Antwerpen, Not set
Rede DoR Recife - PE, Recife, Pernambuco
Liga Norte Riograndense Contra o Cancer | Centro de Pesquisa Clínica, Natal, Rio Grande Do Norte
Irmandade Santa Casa de Misericordia de Porto Alegre | Oncology, Porto Alegre, Rio Grande Do Sul
Centro de Pesquisa da Clínica de Oncologia Reichow, Blumenau, Santa Catarina
Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos, Sao Paulo
Hospital de Base | Integrated Research Center, São José do Rio Preto, Sao Paulo
NAIC - Instituto do Cancer, Bauru, Not set
Hospital Sirio-Libanes (HSL) - Centro de Oncologia - Brasilia, Brasilia, Not set
Pronutrir Fortaleza - CE, Fortaleza, Not set
Hospital Sirio Libanes, Sao Paulo, Not set
A Beneficencia Portuguesa de Sao Paulo - Hospital BP Mirante, Sao Paulo, Not set
Centro Paulista de Oncologia (CPO) - Sao Paulo - Faria Lima, Sao Paulo, Not set
MHAT Uni Hospital, Panagyurishte, Pazardzhik
MHAT "Heart and brain" Pleven, Pleven, Not set
Complex Oncology Center - Plovdiv EOOD, Plovdiv, Not set
MHAT Park Hospital EOOD, Plovdiv, Not set
Multiprofile Hospital for Active Treatment "Sveta Sofia", Sofia, Not set
MHAT Serdika, Sofia, Not set
Specialized Hospital for Active Treatment of Oncology, Sofia, Not set
University Multiprofile Hospital For Active Treatment Sofiamed OOD, Sofia, Sofia, Not set
MHAT Sveta Marina EAD, Varna, Not set
BC Cancer - Vancouver Site, Vancouver, British Columbia
Brampton Civic Hospital - Oncology, Brampton, Ontario
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto, Ontario
Jewish General Hospital - Department of Pulmonary Oncology, Montreal, Quebec
Beijing Cancer Hospital - Oncology Department, Beijing, Beijing
Beijing Hospital, Beijing, Beijing
Fujian Cancer Hospital, Fuzhou, Fujian
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Union Hospi, Tongji Med College, Huazhong Univ. Scien&Tech, Wuhan, Hubei
Hubei Cancer Hospital, Wuhan, Hubei
Hunan Cancer Hospital - Oncology Department, Changsha, Hunan
NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu
Jilin Cancer Hospital, Changchun, Jilin
Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, Shanghai
West China Hospital Sichuan University, Chengdu, Sichuan
Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Zhejiang University School of Medicine - Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Not set
The People's Liberation Army General Hospital (Beijing 301 Hospital), Beijing, Not set
Beijing chest hospital, Capital Medical University, Beijing, Not set
University of Electronic Science & Technology of China - Sichuan Cancer Hospital & Institute (Sichuan Provincial Tumor Hospital), Chengdu, Not set
Guangzhou Medical University - The First Affiliated Hospital, Guangzhou, Not set
Shandong University - Shandong Cancer Hospital, Jinan, Not set
LinYi Cancer Hospital (Linyi Tumor Hospital), Linyi, Not set
Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University, Nanjing, Not set
Guangxi Medical University (GXMU) - Affiliated Tumor Hospital, Nanning, Not set
Zhongshan Hospital, Fudan University - Oncology Department, Shanghai, Not set
Xiamen University - The First Affiliated Hospital, Xiamen, Not set
Krajská nemocnice T. Bati - Pneumoonkologická a klinická onkologie, Zlin, Zlinsky Kraj
Masarykova Univerzita - Masarykuv Onkologicky Ustav (MOU) - Klinika Komplexni Onkologicke Pece (KKOP), Brno, Not set
Nemocnice AGEL Nový Jicín a.s. - Oddelení radioterapie a onkologie, Nový Jicín, Not set
Fakultní Nemocnice Olomouc - Klinika plicních nemocí a tuberkulózy, Olomouc, Not set
Nemocnice AGEL Ostrava-Vítkovice a. s. - Plicní oddelení, Ostrava - Vítkovice, Not set
Aalborg University hospital - oncology department, Aalborg, Not set
Aarhus Universitetshospital, Aarhus N, Not set
Rigshospitalet - Kræftbehandling, Copenhagen OE, Not set
Regionshospitalet Gødstrup - Medicinsk afdeling, Herning, Not set
Odense University Hospital - Oncology Department, Odense C, Not set
Docrates Mehiläinen Syöpäsairaala, Helsinki, Not set
Turun yliopistollinen keskussairaala, Turku, Not set
Institut Bergonie - Unicancer Nouvelle Aquitaine, Bordeaux, Not set
Hopital La Cavale Blanche - CHU de Brest - institut de cancerologie et d'imagerie, Brest, Not set
Centre Hospitalier Intercommunal Creteil - Service de pneumologie, Créteil, Not set
Centre Hospitalier Michallon Grenoble - Service pneumologie, La Tronche, Not set
Institut Coeur Poumon CHRU Lille - Pole Cardio-vasculaire et pulmonaire, Lille, Not set
Centre Hospitalier Universitaire de Limoges - unite oncologie thoracique, Limoges, Not set
CHU Montpellier - Hopital Arnaud de Villeneuve - Service oncologie thoracique, Montpellier, Not set
hopital Emile Muller - Service Pneumologie, Mulhouse, Not set
Hopital Nord Laennec - Oncologie medicale thoracique et digestive, Nantes, Not set
Centre Antoine Lacassagne - Departement Oncologie, Nice, Not set
hopital cochin APHP - service de pneumologie, Paris, Not set
Institut Curie - Paris - Oncologie medicale, Paris, Not set
hopital Lyon sud HCL - Pneumologie aigue specialisee et cancerologie thoracique, Pierre Bénite, Not set
CHU de Rouen - Hopital Charles Nicolle - Service de Pneumologie, Rouen, Not set
Institut de Cancerologie Ouest - Saint-Herblain, Saint-Herblain, Not set
Hopital Foch - Oncologie digestive et thoracique, Suresnes, Not set
Gustave Roussy - Departement Oncologie-Radiotherapie, Villejuif, Not set
Universitaetsklinikum Giessen und Marburg - Medizinische Klinik IV Organonkologie, Giessen, Hessen
Kliniken der Stadt Köln gGmbH - Krankenhaus Merheim - Lungenklinik, Köln, Nordrhein-Westfalen
Universitaetsklinikum Essen - Innere Klinik (Tumorforschung), Essen, North Rhine-Westphalia
Charité Universitätsmedizin Berlin CBF - Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Berlin, Not set
Universitätsklinikum Frankfurt - Medizinische Klinik II, Hämatologie und Onkologie, Frankfurt, Not set
Lungenklinik Hemer, Thorakale Onkologie und onkologische Palliativmedizin, Hemer, Not set
Klinikum Nürnberg - Klinik für Innere Medizin 3, Schwerpunkt Pneumologie (Lungenheilkunde), Nürnberg, Not set
Robert Bosch Krankenhaus - Haematologie, Onkologie und Palliativmedizin, Stuttgart, Not set
?enry Durant Hospital Center-4th Oncology Department and Clinical Trials Unit, Athens, Not set
University of Athens Medical School-Sotiria General Hospital - 3rd Dept of Medicine & Medical Oncology, Athens, Not set
General Hospital of Athens "Alexandra''-Plasma Cell Dyscrasias,Department of Clinical Therapeutics,School of Medicine,NKUA, Athens, Not set
University General Hospital ATTIKON, Department of Internal Medicine IV, Chaidari, Not set
University General Hospital of Athens "ATTIKON", Chaidari, Not set
University General Hospital of Larissa, Larissa, Not set
Metropolitan Hospital- 4th Oncology Clinic, Piraeus, Not set
Bioclinic Thessaloniki, Thessaloniki, Not set
PAPANIKOLAOU General Hospital of Thessaloniki, Thessaloniki, Not set
Prince of Wales Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Queen Elizabeth Hospital Hong Kong, Hong Kong, Not set
Hong Kong United Oncology Centre, Kowloon, Not set
Budapesti Uzsoki Utcai Korhaz - Tüdogyógyászati Osztály, Budapest, Not set
Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabanya, Not set
Assuta Ashdod Public Hospital (R.A), Ashdod, Not set
Soroka Medical Center- Legacy Heritage Cancer Center, Be'er Sheva, Not set
Shaare Zedek Medical Center (SZMC), Jerusalem, Not set
Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set
AORN San Giuseppe Moscati Avellino - U.O.C. Oncologia Medica, Avellino, Campania
Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - UOC Oncologia Medica, Bologna, Emilia-Romagna
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. - GDP Toracica, Meldola, Emilia-Romagna
Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati, Aviano, Friuli-Venezia Giulia
I.F.O. Istituti Fisioterapici Ospitalieri_Ospedale Regina Elena -- Oncologia Medica 2, Roma, Lazio
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOSD Oncologia Toraco-Polmonare, Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1, Milano, Lombardia
Istituto Europeo di Oncologia s.r.l - Oncologia Toracica, Milano, Lombardia
Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia, Rozzano, Lombardia
Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Oncologia Medica, Orbassano, Piemonte
Istituto Oncologico Veneto_Padova - UOC Oncologia 2, Padova, Veneto
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Ospedale Vito Fazzi Lecce - Oncologia, Lecce, Not set
Ospedale San Raffaele s.r.l. - Oncologia Medica, Milano, Not set
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello - Oncologia Medica, Palermo, Not set
ASST Sette Laghi_Ospedale Macchi - Oncologia, Varese, Not set
Centro Ricerche Cliniche Di Verona S.r.l. - Oncologia, Verona, Not set
National Hospital Organization Nagoya Medical Center, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
Hokkaido University Hospital, Sapporo, Hokkaido
National Hospital Organization Himeji Medical Center, Himeji, Hyogo
Kobe University Hospital, Kobe, Hyogo
Kitasato University Hospital, Sagamihara, Kanagawa
Sendai Kousei Hospital, Sendai, Miyagi
Kansai Medical University Hospital, Hirakata, Osaka
Kindai University Hospital, Osakasayama, Osaka
Saitama Cancer Center, Kitaadachi-gun, Saitama
Nippon Medical School - Nippon Medical School Hospital - Cancer Center, Bunkyo-ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization-Yamaguchi-Ube Medical Center (Sanyo Hospital), Ube, Yamaguchi
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Osaka International Cancer Institute, Osaka, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbugdo
Gyeongsang National University Hospital, Jinju-si, Gyeongsangnam-do
Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnamdo
Severance Hospital, Yonsei University Health System - Oncology Department, Seoul, Seoul Teugbyeolsi
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Chonnam National University Hwasun Hospital, Hwasun Gun, Not set
Samsung Medical Center - Oncology Department, Seoul, Not set
Beacon Hospital, Petaling Jaya, Selangor
Columbia Asia Hospital Bukit Rimau, Shah Alam, Selangor
Sunway Medical Centre, Subang Jaya, Selangor
University Hospital Kebangsaan Malaysia, Cheras, Not set
Gleneagles Penang Medical Center, George Town,, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Sunway Medical Centre Penang, Perai, Not set
Instituto Nacional de Cancerología, Mexico, Distrito Federal
Oncare Viaducto Nápoles, Cdmx, Not set
Oncología Integral Satélite, Naucalpan, Not set
Hospital Universitrio Dr. José Eleuterio González. Servicio de Oncologia, Nuevo León, Not set
Clinica Integral Internacional de Oncologia S. de R.L. de C.V., Puebla, Not set
ONCARE Treatment Center, San Pedro Garza García, Not set
Nederlands Kanker Instituut, Amsterdam, Not set
Radboud University Medical Center | Afdeling Interne Geneeskunde, Nijmegen, Not set
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Not set
Swietokrzyskie Centrum Onkologii, Kielce, Not set
Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Lodzi, Lodz, Not set
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwock, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan, Not set
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw, Not set
Hospital Pedro Hispano | Clinical Research Center, Matosinhos, Porto
Unidade Local Saúde Coimbra, E.P.E, Coimbra, Not set
Fundacao Champalimaud | Centro Clinico Champalimaud - Unidade Investigacao Clinica, Lisboa, Not set
CHULN - Hospital Pulido Valente, Lisboa, Not set
IPO Porto, Porto, Not set
Radiotherapy Center Cluj SRL, Flore?ti, Comuna Floresti
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu (IOB); Oncologie Medicala II, Bucuresti, Not set
Spitalul Clinic Coltea, Bucuresti, Not set
CardioMed S.R.L., Cluj-Napoca, Not set
Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca, Not set
Sc Oncolab Srl, Craiova, Not set
Centrul de Oncologie Sfantul Nectarie, Craiova, Not set
S.C Ovidius Clinical Hospital SRL - Oncology Department, Ovidiu, Not set
Oncocenter, Timisoara, Not set
Raffles Cancer Centre, Singapore, Not set
OncoCare Cancer Centre | Gleneagles Medical Centre, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Curie Oncology | Farrer, Singapore, Not set
POKO Poprad s.r.o., Poprad, Not set
Fakultna nemocnica Trnava, Trnava, Not set
Hospital Universitario Puerta De Hierro De Majadahonda - Oncologia, Majadahonda, Madrid
Complejo Hospitalario Universitario A Coruna (CHUAC), A Coruna, Not set
Institut Catala d'Oncologia (ICO) - Hospital Universitari Germans Trias i Pujol (HUGTP) Location, Badalona, Not set
Hospital Quiron Dexeus - Oncologia, Barcelona, Not set
Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona, Not set
Hospital General Universitario Gregorio Maranon | Oncologia, Madrid, Not set
Hospital Universitario Ramon Y Cajal - Oncologia, Madrid, Not set
Hospital Universitario Fundacion Jimenez Diaz- Oncology Service, Madrid, Not set
Hospital Universitario De Navarra - Oncologia, Pamplona, Not set
Fundacion Instituto Valenciano de Oncologia (IVO, Valencia, Not set
Hospital Universitario Y Politecnico La Fe - Oncologia, Valencia, Not set
Skåne University Hospital, Lund, Not set
Norrland University Hospital - Cancercentrum, Umeå, Not set
Kantonsspital Baden, Baden, Aargau
HFR Freiburg - Kantonsspital, Fribourg, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Kaohsiung
National Cheng Kung University Hospital, Tainan, TNN
Chung Shan Medical University Hospital, Taichung, Not set
Taichung Veterans General Hospital, Taichung, Not set
Chi-Mei Medical Center, Liouyine, Tainan, Not set
National Taiwan University Hospital (NTUH) - Cancer Research Center, Taipei, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Ankara Bilkent Sehir Hastanesi, Bilkent Ankara, Not set
Marmara University Hospital, Istanbul, Not set
Ege Universitesi Tip Fakultesi, Izmir, Not set
Istanbul Medeniyet Üniversitesi Göztepe Süleyman Yalçin Sehir Hastanesi, Kadikoy, Not set
I.A.Ü. VM Medical Park Florya Hastanesi, Kucukcekmece, Not set
Sakarya Universitesi Egitim ve Arastirma Hastanesi, Sakarya, Not set
Ankara Etlik Sehir Hastanesi, Yenimahalle, Not set
Adana Sehir Egitim ve Arastirma Hastanesi, Yuregir, Not set
LLC "RDP Ukraine" - Medical Department, Dnipro, Not set
Private Enterprise Private Production Company "Acinus", Treatment and Diagnostic Center, Kropyvnytskyi, Not set
Kyiv City Clinical Oncology Center - Department of Chemotherapy #1, Kyiv, Not set
Limited Liability Company "MedOffice Group Medical Center", Kyiv, Not set
Medical Center LLC "Verum Expert Clinic", Kyiv, Not set
Volyn Regional Oncology Center, Lutsk, Not set
Municipal Enterprise 'Rivne Regional Antitumor Center" of the Rivne Regional Council", Rivne, Not set
MNCE "Uzhhorod City Multidisciplinary Clinical Hospital" -Oncology Department, Uzhhorod, Not set
Torbay Hospital, Torquay, Devon
Belfast City Hospital, Belfast, North Ireland
Royal Surrey County Hospital, Guildford, Surrey
Velindre University NHS Trust | Velindre Cancer Centre - Clinical Trials Unit, Cardiff, Not set
Conditions: Advanced Non-small Cell Lung Cancer, HER2 Mutation
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
Recruiting
The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).
The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only). Read Less
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
07/25/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +183 locations
University of Alabama at Birmingham, Birmingham, Alabama
First OC Dermatology, Fountain Valley, California
Los Angeles Universal Research Center, Los Angeles, California
Paradigm Clinical Research Center Inc, San Diego, California
Wolverine Clinical Trials, Tustin, California
Direct Helpers Research Center, Hialeah, Florida
Wellness Clinical Research, Miami Lakes, Florida
Southern Clinical Research, Miami, Florida
University of Miami Hospital, Miami, Florida
Miami Dermatology and Laser Institute, Miami, Florida
Clinical Research Trials of Florida Inc, Tampa, Florida
Olympian Clinical Research - Tampa, Tampa, Florida
Emory University, Atlanta, Georgia
Endeavor Health Clinical Trials Center, Skokie, Illinois
The Indiana Clinical Trials Center PC, Plainfield, Indiana
Revival Research Institute, LLC, Troy, Michigan
Icahn School of Medicine at Mount Sinai, New York, New York
Optima Research, Boardman, Ohio
University Hospitals Cleveland Medical Center, Cleveland, Ohio
Wright State Physicians, Fairborn, Ohio
Hightower Clinical, Oklahoma City, Oklahoma
Center For Clinical Studies PLLC, Houston, Texas
Clarity Dermatology, Lancaster, Texas
Springville Dermatology, Springville, Utah
Hospital Universitario Austral, Derqui, Pilar, Buenos Aires
Instituto de Investigaciones Clinicas de Cordoba, Cordoba, Córdoba
Instituto de Neumonologia y Dermatologia, Ciudad Autonoma de Buenos Aires, Distrito Federal
Derma Internacional, Ciudad Autonoma de Buenos Aires, Distrito Federal
Centro de investigacion clinica y epidemiologica, San Miguel D Tucuman, Tucuman
Parra Dermatologia, Mendoza, Not set
St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales
Veracity Clinical Research, Woolloongabba, Queensland
Box Hill Hospital, Box Hill, Victoria
The Alfred Hospital, Melbourne, Victoria
The Royal Melbourne Hospital, Parkville, Victoria
Medizinische Universitaet Graz, Graz, Not set
Ordensklinikum Linz Elisabethinen, Linz, Not set
Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Not set
Universitaire Ziekenhuizen Leuven Gasthuisberg, Leuven, Not set
Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, Not set
Clinica Instituto Bahiano de Imunoterapia - Medicina, Reumatologia e Dermatologia ltda, Salvador, Bahia
Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul
Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu, São Paulo
IBPClin Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, Not set
Doctor Chih-Ho Hong Medical Incorporated, Surrey, British Columbia
CCA Medical Research Corp, Ajax, Ontario
Centricity Research London Victoria, London, Ontario
Lovegrove Dermatology, London, Ontario
Lynderm Research Inc, Markham, Ontario
SKiN Centre for Dermatology, Peterborough, Ontario
York Dermatology Clinic and Research Centre, Richmond Hill, Ontario
Toronto Research Centre Inc, Toronto, Ontario
AvantDerm, Toronto, Ontario
Alliance Clinical Trials, Waterloo, Ontario
Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec, Not set
Enroll SpA, Providencia, Santiago
Centro Medico Skinmed Spa, Santiago, Not set
Fundacion Innovacion Cardiovascular Clinica Ensenada, Santiago, Not set
Centro Internacional de Estudios Clinicos, Santiago, Not set
Clinical Research Chile SpA, Valdivia, Not set
Peking University First Hospital, Beijing, Beijing
Peking University Third Hospital, Beijing, Beijing
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian
The First Affiliated Hospital Sun-Yat Sen University, Guangzhou, Guangdong
Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong
Nanfang Hospital Southern Medical University, Guangzhou, Guangdong
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi
Sanmenxia Central Hospital, Sanmenxia, Henan
The Second Xiangya Hospital of Central South University, Changsha, Hunan
Wuxi Peoples Hospital, Wuxi, Jiangsu
Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi
The First Bethune Hospital of Jilin University, Changchun, Jilin
The Second Affiliated Hospital Of Xi An Jiaotong University, XI An, Shaanxi
Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai
Shanghai Skin Disease Hospital, Shanghai, Shanghai
Chengdu Second Peoples Hospital, Chengdu, Sichuan
West China Hospital of Sichuan University, Chengdu, Sichuan
Tianjin Medical University General Hospital, Tianjin, Tianjin
The Second Affliated Hospital of Kunming Medical University, Kunming, Yunnan
Affiliated Hangzhou First Peoples Hospital School of Medicine Westlake University, Hangzhou, Zhejiang
Clinical Research Services Helsinki, Helsinki, Not set
Oulun Yliopistollinen sairaala, Oulu, Not set
Terveystalo Tampere, Tampere, Not set
Centre Hospitalier Regional Universitaire de Brest - Hopital Morvan, Brest, Not set
Centre Hospitalier Le Mans, Le Mans Cedex 9, Not set
Cabinet du Docteur Ruer-Mulard Mireille, Martigues, Not set
Centre Hospitalier Universitaire Archet 2, Nice, Not set
Centre Hospitalier Universitaire de Rouen - Hopital Charles Nicolle, Rouen Cedex, Not set
Universitaetsklinikum Augsburg, Augsburg, Not set
Fachklinik Bad Bentheim, Bad Bentheim, Not set
Charite - Universitaetsmedizin Berlin, Campus Virchow, Berlin, Not set
Rosenpark Research GmbH, Darmstadt, Not set
Universitaetsklinikum Dresden, Dresden, Not set
Universitaetsklinikum Schleswig-Holstein, Kiel, Not set
Universitaetsmedizin Mainz, Mainz, Not set
Universitaetsklinikum Muenster, Muenster, Not set
Hautarztpraxis Mortazawi, Remscheid, Not set
Universitaetsklinikum Tuebingen, Tuebingen, Not set
Helios Klinikum Wuppertal, Wuppertal, Not set
University General Hospital Attikon, Athens, Not set
Andreas Syngros Hospital Of Venereal And Dermatological Diseases, Athens, Not set
General Hospital Of Nea Ionia Konstantopouleio Patision, Nea Ionia, Not set
Ippokratio General Hospital of Thessaloniki, Thessaloniki, Not set
Papageorgiou General Hospital, Thessaloniki, Not set
Queen Mary Hospital, The University of Hong Kong, Hong Kong, Not set
Obudai Egeszsegugyi Centrum Kft, Budapest, Not set
Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set
Derm-Surg Kft, Kaposvar, Not set
DermaMed Research Kft, Oroshaza, Not set
Pecsi Tudomanyegyetem Klinikai Kozpont, Pecs, Not set
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged, Not set
Ospedale San Salvatore, LAquila, Not set
Azienda Ospedaliera Luigi Sacco, Milano, Not set
Azienda Ospedaliero Universitaria di Modena, Modena, Not set
Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia, Perugia, Not set
Fondazione Policlinico Tor Vergata, Roma, Not set
Fujita Health University Hospital, Toyoake-shi, Aichi
Ogaki Municipal Hospital, Ogaki-shi, Gifu
Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo-shi, Hokkaido
Mito Kyodo General Hospital, Mito-shi, Ibaraki
Kochi Medical School Hospital, Nankoku-shi, Kochi
Noguchi Dermatology Clinic, Kamimashiki-gun, Kumamoto
Nagasaki University Hospital, Nagasaki-shi, Nagasaki
Hayami Dermatology Clinic, Osaka-shi, Osaka
Dokkyo Medical University Saitama Medical Center, Koshigaya-shi, Saitama
National Defense Medical College hospital, Tokorozawa-shi, Saitama
Institute of Science Tokyo Hospital, Bunkyo-ku, Tokyo
Tokyo Teishin Hospital, Chiyoda-ku, Tokyo
Shirasaki Dermatology Clinic, Takaoka-shi, Toyama
Tokyo Medical University Hospital, Shinjyuku-ku, Not set
Korea University Ansan Hospital, Ansansi, Gyeonggido, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Hanyang University Seoul Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Hallym University Kangnam Sacred Heart Hospital, Seoul, Not set
J Kisis, Riga, Not set
Outpatient clinic Veselibas Centrs 4, Riga, Not set
Outpatient clinic Veselibascentrs 4, Riga, Not set
Universitair Medisch Centrum Utrecht, Utrecht, Not set
Niepubliczny Zaklad Opieki Zdrowotnej, Bialystok, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy, Gdansk, Not set
GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero, Katowice, Not set
Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne, Lodz, Not set
Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, Not set
Uniwersytecki Szpital Kliniczny imienia Fryderyka Chopina w Rzeszowie, Rzeszow, Not set
Centrum Zdrowia Dziecka i Rodziny Im Jana Pawla II w Sosnowcu Osrodek Badan Klinicznych, Sosnowiec, Not set
Royalderm Agnieszka Nawrocka, Warszawa, Not set
Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spolka Partnerska, Wroclaw, Not set
DermMedica Spzoo Centrum Columbus, Wroclaw, Not set
Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisboa, Not set
Hospital Cuf Descobertas, Lisboa, Not set
Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio, Porto, Not set
Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca, Not set
Spitalul Clinic Judetean Mures, Targu Mures, Not set
Hospital Universitario Reina Sofia, Cordoba, Andalucía
Hospital Universitario Miguel Servet, Zaragoza, Aragón
Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Canarias
Hospital Universitari Germans Trias i Pujol, Badalona, Cataluña
Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluña
Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana
Hospital Universitario de La Princesa, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Diagnostiskt Centrum Hud i Sickla, Nacka, Not set
Akademiska sjukhuset, Uppsala, Not set
Inselspital Bern, Bern, Not set
Universitaetsspital Zuerich, Zuerich Flughafen, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
National Taiwan University Hospital, Taipei, Not set
Mackay Memorial Hospital Taipei Branch, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Linkou Chang Gung Memorial Hospital, Taoyuan, Not set
Ankara Bilkent Sehir Hastanesi, Ankara, Not set
Adnan Menderes Universitesi Medical Faculty, Aydin, Not set
Pamukkale Universitesi Tip Fakultesi Hastanesi, Denizli, Not set
Gaziantep Universitesi Tip Fakultesi Hastanesi, Gaziantep, Not set
Izmir Demokrasi Universitesi Buca Seyfi Demirsoy Egitim ve Arastirma Hastanesi, Izmir, Not set
Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun, Not set
Chapel Allerton Hospital, Leeds, Not set
Royal London Hospital, London, Not set
Guys Hospital, London, Not set
Ameli-Biogroup Limited, Waltham Abbey, Not set
Conditions: Prurigo Nodularis
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Recruiting
A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.
A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy. Read Less
Gender:
ALL
Ages:
65 years and above
Trial Updated:
07/25/2025
Locations: Anthos Investigative Site 1040, Birmingham, Alabama +552 locations
Anthos Investigative Site 1040, Birmingham, Alabama
Anthos Investigative Site 1041, Mobile, Alabama
Anthos Investigative Site 1089, Gilbert, Arizona
Anthos Investigative Site 1099, Peoria, Arizona
Anthos Investigative Site 9906, Phoenix, Arizona
Anthos Investigative Site 9927, Yuma, Arizona
Anthos Investigative Site 9929, Huntington Beach, California
Anthos Investigative Site 9921, Lancaster, California
Anthos Investigative Site 1078, Loma Linda, California
Anthos Investigative Site 1077, Los Angeles, California
Anthos Investigative Site 1015, Northridge, California
Anthos Investigative Site 1070, Redding, California
Anthos Investigative Site 1071, San Dimas, California
Anthos Investigative Site 1076, Santa Ana, California
Anthos Investigative Site 9938, Santa Rosa, California
Anthos Investigative Site 9908, South Gate, California
Anthos Investigative Site 9907, Vista, California
Anthos Investigative Site 1095, Aurora, Colorado
Anthos Investigative Site 1049, Denver, Colorado
Anthos Investigative Site 9922, Golden, Colorado
Anthos Investigative Site 1012, Stamford, Connecticut
Anthos Investigative Site 1013, Boca Raton, Florida
Anthos Investigative Site 1025, Clearwater, Florida
Anthos Investigative Site 1022, Clearwater, Florida
Anthos Investigative Site 1019, Daytona Beach, Florida
Anthos Investigative Site 9936, Hialeah, Florida
Anthos Investigative Site 1083, Hollywood, Florida
Anthos Investigative Site 1008, Jacksonville, Florida
Anthos Investigative Site 9904, Lake Mary, Florida
Anthos Investigative Site 1093, Lutz, Florida
Anthos Investigative Site 1072, Miami Lakes, Florida
Anthos Investigative Site 9933, Miami, Florida
Anthos Investigative Site 9940, Ocala, Florida
Anthos Investigative Site 1067, Ormond Beach, Florida
Anthos Investigative Site 1026, Safety Harbor, Florida
Anthos Investigative Site 1002, Saint Augustine, Florida
Anthos Investigative Site 1004, Saint Augustine, Florida
Anthos Investigative Site 1044, Tamarac, Florida
Anthos Investigative Site 1088, Tamarac, Florida
Anthos Investigative Site 1046, Tampa, Florida
Anthos Investigative Site 9911, The Villages, Florida
Anthos Investigative Site 1052, Lithonia, Georgia
Anthos Investigative Site 1033, Macon, Georgia
Anthos Investigative Site 1042, Norcross, Georgia
Anthos Investigative Site 1003, Suwanee, Georgia
Anthos Investigative Site 1030, Park Ridge, Illinois
Anthos Investigative Site 9925, Winfield, Illinois
Anthos Investigative Site 9915, Evansville, Indiana
Anthos Investigative Site 1098, Merrillville, Indiana
Anthos Investigative Site 1016, Wichita, Kansas
Anthos Investigative Site 1006, Alexandria, Louisiana
Anthos Investigative Site 1043, Shreveport, Louisiana
Anthos Investigative Site 1054, Bangor, Maine
Anthos Investigative Site 1039, Baltimore, Maryland
Anthos Investigative Site 1023, Lanham, Maryland
Anthos Investigative Site 1028, Rockville, Maryland
Anthos Investigative Site 1082, Boston, Massachusetts
Anthos Investigative Site 1021, Lansing, Michigan
Anthos Investigative Site 1059, Southgate, Michigan
Anthos Investigative Site 1017, Tupelo, Mississippi
Anthos Investigative Site 1080, Kansa City, Missouri
Anthos Investigative Site 1066, Lincoln, Nebraska
Anthos Investigative Site 1036, Las Vegas, Nevada
Anthos Investigative Site 9914, Las Vegas, Nevada
Anthos Investigative Site 1094, Englewood, New Jersey
Anthos Investigative Site 9931, Albany, New York
Anthos Investigative Site 9905, Brooklyn, New York
Anthos Investigative Site 1014, Middletown, New York
Anthos Investigative Site 1037, Rosedale, New York
Anthos Investigative Site 9920, Valhalla, New York
Anthos Investigative Site 9924, Westfield, New York
Anthos Investigative Site 1065, Cary, North Carolina
Anthos Investigative Site 1005, Charlotte, North Carolina
Anthos Investigative Site 9912, Durham, North Carolina
Anthos Investigative Site 1048, Fayetteville, North Carolina
Anthos Investigative Site 1035, Henderson, North Carolina
Anthos Investigative Site 1001, Lenoir, North Carolina
Anthos Investigative Site 9902, Beavercreek, Ohio
Anthos Investigative Site 9917, Oklahoma City, Oklahoma
Anthos Investigative Site 1075, Portland, Oregon
Anthos Investigative Site 1074, Bristol, Pennsylvania
Anthos Investigative Site 1087, Horsham, Pennsylvania
Anthos Investigative Site 1032, Rock HIll, South Carolina
Anthos Investigative Site 1050, Elizabethton, Tennessee
Anthos Investigative Site 1057, Germantown, Tennessee
Anthos Investigative Site 1056, Memphis, Tennessee
Anthos Investigative Site 9928, Allen, Texas
Anthos Investigative Site 9913, Beaumont, Texas
Anthos Investigative Site 1091, El Paso, Texas
Anthos Investigative Site 9930, Greenville, Texas
Anthos Investigative Site 1069, Houston, Texas
Anthos Investigative Site 1068, Houston, Texas
Anthos Investigative Site 1097, Houston, Texas
Anthos Investigative Site 9903, Houston, Texas
Anthos Investigative Site 1053, Houston, Texas
Anthos Investigative Site 1064, Houston, Texas
Anthos Investigative Site 9901, Laredo, Texas
Anthos Investigative Site 1063, McAllen, Texas
Anthos Investigative Site 1096, McKinney, Texas
Anthos Investigative Site 1079, McKinney, Texas
Anthos Investigative Site 1024, Odessa, Texas
Anthos Investigative Site 1085, Port Arthur, Texas
Anthos Investigative Site 9923, Sherman, Texas
Anthos Investigative Site 1090, Sugar Land, Texas
Anthos Investigative Site 1011, Tomball, Texas
Anthos Investigative Site 9916, Tyler, Texas
Anthos Investigative Site 9910, Victoria, Texas
Anthos Investigative Site 1060, Waco, Texas
Anthos Investigative Site 9909, Webster, Texas
Anthos Investigative Site 1092, Wylie, Texas
Anthos Investigative Site 1084, American Fork, Utah
Anthos Investigative Site 1031, Bountiful, Utah
Anthos Investigative Site 1029, Holladay, Utah
Anthos Investigative Site 1038, Pleasant View, Utah
Anthos Investigative Site 1034, Roy, Utah
Anthos Investigative Site 1018, Falls Church, Virginia
Anthos Investigative Site 1010, Manassas, Virginia
Anthos Investigative Site 1009, Roanoke, Virginia
Anthos Investigative Site 9926, Redmond, Washington
Anthos Investigative Site 1073, Tacoma, Washington
Anthos Investigative Site 1411, Buenos Aires, Not set
Anthos Investigative Site 1430, Buenos Aires, Not set
Anthos Investigative Site 1409, Ciudad Autónoma Buenos Aires, Not set
Anthos Investigative Site 1410, Ciudad Autónoma de Buenos Aire, Not set
Anthos Investigative Site 1423, Ciudad Autónoma de Buenos Aire, Not set
Anthos Investigative Site 1429, Coronel Suárez, Not set
Anthos Investigative Site 1420, Corrientes, Not set
Anthos Investigative Site 1407, Córdoba, Not set
Anthos Investigative Site 1414, Córdoba, Not set
Anthos Investigative Site 1418, Córdoba, Not set
Anthos Investigative Site 1424, Córdoba, Not set
Anthos Investigative Site 1427, Córdoba, Not set
Anthos Investigative Site 1434, Córdoba, Not set
Anthos Investigative Site 1419, Córdoba, Not set
Anthos Investigative Site 1431, Córdoba, Not set
Anthos Investigative Site 1402, La Plata, Not set
Anthos Investigative Site 1417, Quilmes, Not set
Anthos Investigative Site 1415, Ramos Mejia, Not set
Anthos Investigative Site 1403, Salta, Not set
Anthos Investigative Site 1425, San Luis, Not set
Anthos Investigative Site 1426, San Martin, Not set
Anthos Investigative Site 1404, San Miguel De Tucumán, Not set
Anthos Investigative Site 1435, San Miguel De Tucumán, Not set
Anthos Investigative Site 1436, San Nicolas, Not set
Anthos Investigative Site 1518, Aracaju, Not set
Anthos Investigative Site 1527, Belo Horizonte, Not set
Anthos Investigative Site 1528, Belo Horizonte, Not set
Anthos Investigative Site 1516, Belo Horizonte, Not set
Anthos Investigative Site 1507, Belo Horizonte, Not set
Anthos Investigative Site 1513, Blumenau, Not set
Anthos Investigative Site 1505, Blumenau, Not set
Anthos Investigative Site 1535, Brasília, Not set
Anthos Investigative Site 1501, Campina Grande Do Sul, Not set
Anthos Investigative Site 1503, Campinas, Not set
Anthos Investigative Site 1522, Campinas, Not set
Anthos Investigative Site 1520, Campo Grande, Not set
Anthos Investigative Site 1532, Canoas, Not set
Anthos Investigative Site 1526, Caxias Do Sul, Not set
Anthos Investigative Site 1542, Colatina, Not set
Anthos Investigative Site 1540, Curitiba, Not set
Anthos Investigative Site 1509, Curitiba, Not set
Anthos Investigative Site 1525, Goiânia, Not set
Anthos Investigative Site 1502, Marília, Not set
Anthos Investigative Site 1533, Passo Fundo, Not set
Anthos Investigative Site 1517, Porto Alegre, Not set
Anthos Investigative Site 1519, Porto Alegre, Not set
Anthos Investigative Site 1506, Porto Alegre, Not set
Anthos Investigative Site 1530, Porto Alegre, Not set
Anthos Investigative Site 1512, Porto Alegre, Not set
Anthos Investigative Site 1524, Porto Alegre, Not set
Anthos Investigative Site 1508, Porto Alegre, Not set
Anthos Investigative Site 1531, Recife, Not set
Anthos Investigative Site 1515, Ribeirão Preto, Not set
Anthos Investigative Site 1536, Ribeirão Preto, Not set
Anthos Investigative Site 1537, Rio De Janeiro, Not set
Anthos Investigative Site 1510, Salvador, Not set
Anthos Investigative Site 1521, Salvador, Not set
Anthos Investigative Site 1534, São Paulo, Not set
Anthos Investigative Site 1511, São Paulo, Not set
Anthos Investigative Site 1538, São Paulo, Not set
Anthos Investigative Site 1539, São Paulo, Not set
Anthos Investigative Site 1529, São Paulo, Not set
Anthos Investigative Site 1543, São Paulo, Not set
Anthos Investigative Site 1514, Tatuí, Not set
Anthos Investigative Site 1541, Teresina, Not set
Anthos Investigative Site 1504, Votuporanga, Not set
Anthos Investigative Site 6014, Blagoevgrad, Not set
Anthos Investigative Site 6026, Burgas, Not set
Anthos Investigative Site 6019, Gabrovo, Not set
Anthos Investigative Site 6032, Haskovo, Not set
Anthos Investigative Site 6018, Haskovo, Not set
Anthos Investigative Site 6013, Panagyurishte, Not set
Anthos Investigative Site 6025, Pazardzhik, Not set
Anthos Investigative Site 6006, Pleven, Not set
Anthos Investigative Site 6003, Pleven, Not set
Anthos Investigative Site 6007, Plovdiv, Not set
Anthos Investigative Site 6008, Plovdiv, Not set
Anthos Investigative Site 6009, Plovdiv, Not set
Anthos Investigative Site 6004, Plovdiv, Not set
Anthos Investigative Site 6021, Plovdiv, Not set
Anthos Investigative Site 6031, Ruse, Not set
Anthos Investigative Site 6027, Sliven, Not set
Anthos Investigative Site 6022, Smolyan, Not set
Anthos Investigative Site 6030, Sofia, Not set
Anthos Investigative Site 6028, Sofia, Not set
Anthos Investigative Site 6029, Sofia, Not set
Anthos Investigative Site 6024, Sofia, Not set
Anthos Investigative Site 6023, Sofia, Not set
Anthos Investigative Site 6010, Sofia, Not set
Anthos Investigative Site 6015, Sofia, Not set
Anthos Investigative Site 6020, Sofia, Not set
Anthos Investigative Site 6001, Sofia, Not set
Anthos Investigative Site 6017, Sofia, Not set
Anthos Investigative Site 6012, Sofia, Not set
Anthos Investigative Site 6002, Sofia, Not set
Anthos Investigative Site 6011, Stara Zagora, Not set
Anthos Investigative Site 2012, Mira Road, Nova Scotia
Anthos Investigative Site 2003, Cambridge, Ontario
Anthos Investigative Site 2007, Chicoutimi, Quebec
Anthos Investigative Site 2010, Sherbrooke, Quebec
Anthos Investigative Site 2016, Abbotsford, Not set
Anthos Investigative Site 2019, Brampton, Not set
Anthos Investigative Site 2015, Edmonton, Not set
Anthos Investigative Site 2018, Greenfield Park, Not set
Anthos Investigative Site 2005, Halifax, Not set
Anthos Investigative Site 2025, Hamilton, Not set
Anthos Investigative Site 2014, Montréal, Not set
Anthos Investigative Site 2004, New Westminster, Not set
Anthos Investigative Site 2021, North Vancouver, Not set
Anthos Investigative Site 2002, Québec, Not set
Anthos Investigative Site 2024, Saint Catharines, Not set
Anthos Investigative Site 2006, Saint-Jérôme, Not set
Anthos Investigative Site 2022, Thunder Bay, Not set
Anthos Investigative Site 2017, Toronto, Not set
Anthos Investigative Site 2020, Toronto, Not set
Anthos Investigative Site 2023, Toronto, Not set
Anthos Investigative Site 1605, Concepción, Not set
Anthos Investigative Site 1606, Independencia, Not set
Anthos Investigative Site 1604, Providencia, Not set
Anthos Investigative Site 1607, San Bernardo, Not set
Anthos Investigative Site 1609, San Miguel, Not set
Anthos Investigative Site 1608, Santiago, Not set
Anthos Investigative Site 1610, Talcahuano, Not set
Anthos Investigative Site 1603, Temuco, Not set
Anthos Investigative Site 1602, Temuco, Not set
Anthos Investigative Site 1601, Viña Del Mar, Not set
Anthos Investigative Site 1818, Changchun, Not set
Anthos Investigative Site 1810, Changsha, Not set
Anthos Investigative Site 1811, Changsha, Not set
Anthos Investigative Site 1802, Chengdu, Not set
Anthos Investigative Site 1809, Haidian, Not set
Anthos Investigative Site 1801, Hangzhou, Not set
Anthos Investigative Site 1808, Hangzhou, Not set
Anthos Investigative Site 1816, Jinan, Not set
Anthos Investigative Site 1804, Lianyungang, Not set
Anthos Investigative Site 1814, Luoyang, Not set
Anthos Investigative Site 1817, Nanchang, Not set
Anthos Investigative Site 1820, Nanchang, Not set
Anthos Investigative Site 1803, Nanjing, Not set
Anthos Investigative Site 1815, Ningbo, Not set
Anthos Investigative Site 1819, Shijiazhuang, Not set
Anthos Investigative Site 1812, Tianjin, Not set
Anthos Investigative Site 1813, Yangzhou, Not set
Anthos Investigative Site 1805, Yinchuan, Not set
Anthos Investigative Site 2504, Barranquilla, Not set
Anthos Investigative Site 3102, Krapinske Toplice, Not set
Anthos Investigative Site 3108, Osijek, Not set
Anthos Investigative Site 3107, Rijeka, Not set
Anthos Investigative Site 3111, Zabok, Not set
Anthos Investigative Site 3109, Zadar, Not set
Anthos Investigative Site 3101, Zagreb, Not set
Anthos Investigative Site 3103, Zagreb, Not set
Anthos Investigative Site 3104, Zagreb, Not set
Anthos Investigative Site 3002, Brandýs Nad Labem, Not set
Anthos Investigative Site 3006, Liberec, Not set
Anthos Investigative Site 3007, Ostrava - Poruba, Not set
Anthos Investigative Site 3001, Poděbrady, Not set
Anthos Investigative Site 3003, Prague, Not set
Anthos Investigative Site 3005, Praha, Not set
Anthos Investigative Site 3004, Praha, Not set
Anthos Investigative Site 3010, Praha, Not set
Anthos Investigative Site 3009, Trutnov, Not set
Anthos Investigative Site 3011, Ústí Nad Labem, Not set
Anthos Investigative Site 2203, Tallinn, Not set
Anthos Investigative Site 2202, Tallinn, Not set
Anthos Investigative Site 2201, Tallinn, Not set
Anthos Investigative Site 7006, Altenburg, Not set
Anthos Investigative Site 7014, Berlin, Not set
Anthos Investigative Site 7004, Dresden, Not set
Anthos Investigative Site 7012, Hamburg, Not set
Anthos Investigative Site 7003, Hamburg, Not set
Anthos Investigative Site 7013, Hannover, Not set
Anthos Investigative Site 7009, Ludwigshafen, Not set
Anthos Investigative Site 7002, Markkleeberg, Not set
Anthos Investigative Site 7007, Paderborn, Not set
Anthos Investigative Site 7001, Schwerin, Not set
Anthos Investigative Site 2704, Athens, Not set
Anthos Investigative Site 2702, Cholargós, Not set
Anthos Investigative Site 2705, Glyfáda, Not set
Anthos Investigative Site 4015, Budapest, Not set
Anthos Investigative Site 4006, Budapest, Not set
Anthos Investigative Site 4009, Budapest, Not set
Anthos Investigative Site 4018, Budapest, Not set
Anthos Investigative Site 4002, Békéscsaba, Not set
Anthos Investigative Site 4011, Gyöngyös, Not set
Anthos Investigative Site 4012, Kaposvar, Not set
Anthos Investigative Site 4007, Kistarcsa, Not set
Anthos Investigative Site 4005, Nyíregyháza, Not set
Anthos Investigative Site 4010, Pécs, Not set
Anthos Investigative Site 4017, Szeged, Not set
Anthos Investigative Site 4016, Veszprém, Not set
Anthos Investigative Site 4008, Zalaegerszeg, Not set
Anthos Investigative Site 2310, Ahmedabad, Not set
Anthos Investigative Site 2320, Ahmedabad, Not set
Anthos Investigative Site 2330, Ajmer, Not set
Anthos Investigative Site 2311, Bangalore, Not set
Anthos Investigative Site 2318, Bhubaneswar, Not set
Anthos Investigative Site 2303, Chandigarh, Not set
Anthos Investigative Site 2324, Chennai, Not set
Anthos Investigative Site 2338, Chennai, Not set
Anthos Investigative Site 2325, Chennai, Not set
Anthos Investigative Site 2328, Dehradun, Not set
Anthos Investigative Site 2308, Ghaziabad, Not set
Anthos Investigative Site 2306, Jaipur, Not set
Anthos Investigative Site 2331, Jaipur, Not set
Anthos Investigative Site 2304, Kochi, Not set
Anthos Investigative Site 2314, Kolkata, Not set
Anthos Investigative Site 2326, Mangaluru, Not set
Anthos Investigative Site 2329, Meerut, Not set
Anthos Investigative Site 2313, Mumbai, Not set
Anthos Investigative Site 2315, Nagpur, Not set
Anthos Investigative Site 2316, Nagpur, Not set
Anthos Investigative Site 2307, New Delhi, Not set
Anthos Investigative Site 2301, New Delhi, Not set
Anthos Investigative Site 2319, New Delhi, Not set
Anthos Investigative Site 2305, Pune, Not set
Anthos Investigative Site 2317, Pune, Not set
Anthos Investigative Site 2309, Secunderabad, Not set
Anthos Investigative Site 2312, Visakhapatnam, Not set
Anthos Investigative Site 2321, Visakhapatnam, Not set
Anthos Investigative Site 1210, Afula, Not set
Anthos Investigative Site 1205, Ashkelon, Not set
Anthos Investigative Site 1213, Be'er Sheva, Not set
Anthos Investigative Site 1206, Hadera, Not set
Anthos Investigative Site 1211, Haifa, Not set
Anthos Investigative Site 1201, Haifa, Not set
Anthos Investigative Site 1209, H̱olon, Not set
Anthos Investigative Site 1212, Jerusalem, Not set
Anthos Investigative Site 1204, Kfar Saba, Not set
Anthos Investigative Site 1202, Nahariya, Not set
Anthos Investigative Site 1207, Petah tikva, Not set
Anthos Investigative Site 1203, Reẖovot, Not set
Anthos Investigative Site 1208, Zefat, Not set
Anthos Investigative Site 8016, Ancona, Not set
Anthos Investigative Site 8003, Bologna, Not set
Anthos Investigative Site 8015, Brescia, Not set
Anthos Investigative Site 8019, Caserta, Not set
Anthos Investigative Site 8008, Catanzaro, Not set
Anthos Investigative Site 8021, Cinisello Balsamo, Not set
Anthos Investigative Site 8024, Firenze, Not set
Anthos Investigative Site 8013, Lecco, Not set
Anthos Investigative Site 8001, Milano, Not set
Anthos Investigative Site 8007, Milan, Not set
Anthos Investigative Site 8026, Naples, Not set
Anthos Investigative Site 8023, Napoli, Not set
Anthos Investigative Site 8017, Palermo, Not set
Anthos Investigative Site 8025, Pisa, Not set
Anthos Investigative Site 8010, Roma, Not set
Anthos Investigative Site 8011, Roma, Not set
Anthos Investigative Site 8002, Roma, Not set
Anthos Investigative Site 8022, Rome, Not set
Anthos Investigative Site 8004, Saronno, Not set
Anthos Investigative Site 8005, Sesto San Giovanni, Not set
Anthos Investigative Site 8014, Torino, Not set
Anthos Investigative Site 8006, Varese, Not set
Anthos Investigative Site 8009, Vittoria, Not set
Anthos Investigative Site 1923, Akashi, Not set
Anthos Investigative Site 1908, Chikushino-shi, Not set
Anthos Investigative Site 1902, Chuo-Ku, Not set
Anthos Investigative Site 1920, Funabashi-Shi, Not set
Anthos Investigative Site 1910, Hamada-shi, Not set
Anthos Investigative Site 1924, Hamamatsu, Not set
Anthos Investigative Site 1906, Himeji-Shi, Not set
Anthos Investigative Site 1911, Imabari-shi, Not set
Anthos Investigative Site 1912, Isehara-Shi, Not set
Anthos Investigative Site 1921, Koto-Ku, Not set
Anthos Investigative Site 1915, Kure-shi, Not set
Anthos Investigative Site 1931, Matsue, Not set
Anthos Investigative Site 1903, Matsumoto-Shi, Not set
Anthos Investigative Site 1907, Nagano-Shi, Not set
Anthos Investigative Site 1929, Naha, Not set
Anthos Investigative Site 1934, Okayama, Not set
Anthos Investigative Site 1932, Osaka, Not set
Anthos Investigative Site 1930, Osaka, Not set
Anthos Investigative Site 1922, Sapporo-shi, Not set
Anthos Investigative Site 1904, Sendai-shi, Not set
Anthos Investigative Site 1913, Shimonoseki-shi, Not set
Anthos Investigative Site 1914, Tachikawa-shi, Not set
Anthos Investigative Site 1909, Tochigi, Not set
Anthos Investigative Site 1925, Tokushima, Not set
Anthos Investigative Site 1933, Tokyo, Not set
Anthos Investigative Site 1928, Toyama, Not set
Anthos Investigative Site 1927, Tōon, Not set
Anthos Investigative Site 1901, Urayasu, Not set
Anthos Investigative Site 1917, Uwajima-Shi, Not set
Anthos Investigative Site 1918, Yokohama-shi, Not set
Anthos Investigative Site 1919, Yokohama-Shi, Not set
Anthos Investigative Site 1916, Yokohama-Shi, Not set
Anthos Investigative Site 1926, Ōmihachiman, Not set
Anthos Investigative Site 2103, Baldone, Not set
Anthos Investigative Site 2109, Balvi, Not set
Anthos Investigative Site 2107, Daugavpils, Not set
Anthos Investigative Site 2108, Limbazi, Not set
Anthos Investigative Site 2110, Riga, Not set
Anthos Investigative Site 2101, Riga, Not set
Anthos Investigative Site 2105, Riga, Not set
Anthos Investigative Site 2102, Riga, Not set
Anthos Investigative Site 2111, Sigulda, Not set
Anthos Investigative Site 2104, Valmiera, Not set
Anthos Investigative Site 2106, Valmiera, Not set
Anthos Investigative Site 1701, Aguascalientes, Not set
Anthos Investigative Site 1707, Aguascalientes, Not set
Anthos Investigative Site 1713, Aguascalientes, Not set
Anthos Investigative Site 1721, Chihuahua, Not set
Anthos Investigative Site 1712, Ciudad De México, Not set
Anthos Investigative Site 1703, Culiacán, Not set
Anthos Investigative Site 1715, Guadalajara, Not set
Anthos Investigative Site 1711, Guerrero, Not set
Anthos Investigative Site 1704, Monterrey, Not set
Anthos Investigative Site 1705, Monterrey, Not set
Anthos Investigative Site 1719, Monterrey, Not set
Anthos Investigative Site 1702, Querétaro, Not set
Anthos Investigative Site 1718, San Luis Potosí, Not set
Anthos Investigative Site 1716, Tlalpan, Not set
Anthos Investigative Site 1706, Veracruz, Not set
Anthos Investigative Site 1708, Veracruz, Not set
Anthos Investigative Site 1709, Xalapa, Not set
Anthos Investigative Site 5029, Białystok, Not set
Anthos Investigative Site 5022, Czeladź, Not set
Anthos Investigative Site 5033, Elbląg, Not set
Anthos Investigative Site 5010, Gdynia, Not set
Anthos Investigative Site 5034, Gdynia, Not set
Anthos Investigative Site 5003, Katowice, Not set
Anthos Investigative Site 5009, Katowice, Not set
Anthos Investigative Site 5030, Katowice, Not set
Anthos Investigative Site 5005, Katowice, Not set
Anthos Investigative Site 5016, Kraków, Not set
Anthos Investigative Site 5018, Kraków, Not set
Anthos Investigative Site 5032, Legnica, Not set
Anthos Investigative Site 5023, Lublin, Not set
Anthos Investigative Site 5006, Lublin, Not set
Anthos Investigative Site 5008, Olsztyn, Not set
Anthos Investigative Site 5025, Oświęcim, Not set
Anthos Investigative Site 5002, Przemyśl, Not set
Anthos Investigative Site 5004, Rzeszów, Not set
Anthos Investigative Site 5001, Tychy, Not set
Anthos Investigative Site 5014, Warszawa, Not set
Anthos Investigative Site 5017, Warszawa, Not set
Anthos Investigative Site 5011, Warszawa, Not set
Anthos Investigative Site 5015, Warszawa, Not set
Anthos Investigative Site 5019, Wrocław, Not set
Anthos Investigative Site 5007, Wrocław, Not set
Anthos Investigative Site 5024, Zabrze, Not set
Anthos Investigative Site 5021, Łódź, Not set
Anthos Investigative Site 5012, Łódź, Not set
Anthos Investigative Site 5028, Łódź, Not set
Anthos Investigative Site 9022, Baloteşti, Not set
Anthos Investigative Site 9028, Braşov, Not set
Anthos Investigative Site 9001, Brăila, Not set
Anthos Investigative Site 9023, Bucharest, Not set
Anthos Investigative Site 9019, Bucuresti, Not set
Anthos Investigative Site 9024, Cluj-Napoca, Not set
Anthos Investigative Site 9017, Craiova, Not set
Anthos Investigative Site 9006, Craiova, Not set
Anthos Investigative Site 9010, Oradea, Not set
Anthos Investigative Site 9025, Piteşti, Not set
Anthos Investigative Site 9014, Piteşti, Not set
Anthos Investigative Site 9012, Satu Mare, Not set
Anthos Investigative Site 9007, Timişoara, Not set
Anthos Investigative Site 9005, Timişoara, Not set
Anthos Investigative Site 9018, Timişoara, Not set
Anthos Investigative Site 9013, Timişoara, Not set
Anthos Investigative Site 9008, Timişoara, Not set
Anthos Investigative Site 9003, Târgu-Mureş, Not set
Anthos Investigative Site 9004, Târgu-Mureş, Not set
Anthos Investigative Site 9016, Târgu-Mureş, Not set
Anthos Investigative Site 9021, Târgu-Mureş, Not set
Anthos Investigative Site 2901, Belgrade, Not set
Anthos Investigative Site 2903, Belgrade, Not set
Anthos Investigative Site 2905, Belgrade, Not set
Anthos Investigative Site 2908, Belgrade, Not set
Anthos Investigative Site 2909, Belgrade, Not set
Anthos Investigative Site 2904, Kragujevac, Not set
Anthos Investigative Site 2906, Smederevo, Not set
Anthos Investigative Site 2902, Užice, Not set
Anthos Investigative Site 2907, Zaječar, Not set
Anthos Investigative Site 2801, Bardejov, Not set
Anthos Investigative Site 2805, Košice, Not set
Anthos Investigative Site 2806, Lučenec, Not set
Anthos Investigative Site 2802, Piešťany, Not set
Anthos Investigative Site 2804, Žilina, Not set
Anthos Investigative Site 2411, Bellville, Not set
Anthos Investigative Site 2409, Benoni, Not set
Anthos Investigative Site 2417, Cape Town, Not set
Anthos Investigative Site 2408, Centurion, Not set
Anthos Investigative Site 2412, Durban, Not set
Anthos Investigative Site 2416, Johannesburg, Not set
Anthos Investigative Site 2402, Pretoria, Not set
Anthos Investigative Site 2414, Pretoria, Not set
Anthos Investigative Site 2415, Somerset West, Not set
Anthos Investigative Site 2405, Tongaat, Not set
Anthos Investigative Site 1108, A Coruña, Not set
Anthos Investigative Site 1116, Almería, Not set
Anthos Investigative Site 1121, Barcelona, Not set
Anthos Investigative Site 1124, Barcelona, Not set
Anthos Investigative Site 1120, Barcelona, Not set
Anthos Investigative Site 1109, Cabra, Not set
Anthos Investigative Site 1103, Granada, Not set
Anthos Investigative Site 1111, Jaén, Not set
Anthos Investigative Site 1118, León, Not set
Anthos Investigative Site 1104, Madrid, Not set
Anthos Investigative Site 1117, Madrid, Not set
Anthos Investigative Site 1106, Madrid, Not set
Anthos Investigative Site 1113, Madrid, Not set
Anthos Investigative Site 1110, Murcia, Not set
Anthos Investigative Site 1105, Málaga, Not set
Anthos Investigative Site 1115, Oviedo, Not set
Anthos Investigative Site 1123, Sabadell, Not set
Anthos Investigative Site 1107, Santiago De Compostela, Not set
Anthos Investigative Site 1102, Sevilla, Not set
Anthos Investigative Site 1122, Sevilla, Not set
Anthos Investigative Site 1112, Terrassa, Not set
Anthos Investigative Site 1101, Valencia, Not set
Anthos Investigative Site 1119, Vigo, Not set
Anthos Investigative Site 3301, Stockholm, Not set
Anthos Investigative Site 1303, Corby, Not set
Anthos Investigative Site 1313, Glasgow, Not set
Anthos Investigative Site 1315, Hayle, Not set
Anthos Investigative Site 1311, High Wycombe, Not set
Anthos Investigative Site 1301, Isleworth, Not set
Anthos Investigative Site 1316, King's Lynn, Not set
Anthos Investigative Site 1309, Leeds, Not set
Anthos Investigative Site 1314, London, Not set
Anthos Investigative Site 1319, London, Not set
Anthos Investigative Site 1308, London, Not set
Anthos Investigative Site 1312, Manchester, Not set
Anthos Investigative Site 1307, Newcastle Upon Tyne, Not set
Anthos Investigative Site 1318, Norwich, Not set
Anthos Investigative Site 1305, Peterborough, Not set
Anthos Investigative Site 1302, Stevenage, Not set
Anthos Investigative Site 1310, Stockton-on-Tees, Not set
Anthos Investigative Site 1317, Stoke-on-Trent, Not set
Anthos Investigative Site 1306, Taunton, Not set
Conditions: Atrial Fibrillation (AF)
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Recruiting
Researchers are looking for a better way to treat people who have advanced metastatic castration-resistant prostate cancer (mCRPC). In participants with metastatic castration-resistant prostate cancer (mCRPC), the cancer of the prostate has spread to other parts of the body (metastatic) and does not respond to the lowering of testosterone levels in the body (castration resistant). The cancer is 'advanced' and is unlikely to be cured or controlled with currently available treatments. Despite new... Read More
Researchers are looking for a better way to treat people who have advanced metastatic castration-resistant prostate cancer (mCRPC). In participants with metastatic castration-resistant prostate cancer (mCRPC), the cancer of the prostate has spread to other parts of the body (metastatic) and does not respond to the lowering of testosterone levels in the body (castration resistant). The cancer is 'advanced' and is unlikely to be cured or controlled with currently available treatments. Despite new treatment options for participant(s) with prostate cancer in recent years, the cancer often returns and worsens.
The study treatment actinium-225-macropa-pelgifatamab (also called 225Ac-pelgi or BAY3546828) is a new type of treatment under development for participants with mCRPC who have already received available treatments or have few treatment options available. It works by binding to a protein on the surface of the cancer cells called prostate specific membrane antigen (PSMA). As it gives off a type of radioactivity that travels a very short distance, it kills the nearby (cancer) cells that express PSMA.
The main purpose of this first-in-human study in participants with mCRPC is to learn:
* How safe different doses of 225Ac-pelgi are.
* To what degree medical problems caused by 225Ac-pelgi can be tolerated by the participants?
* Which dose of 225Ac-pelgi is optimal for treatment (safe and working well)?
* How good is 225Ac-pelgi's anticancer activity?
To answer this, the researchers will look at:
* The number and severity of medical problems that the participants have after treatment with 225Ac-pelgi (per dose level).
* The ratio of medical problems and anticancer activity per dose.
* Anticancer activity of the optimal 225Ac-pelgi dose as proportion of participants who have at least halved prostate-specific antigen (PSA) levels after 12 weeks of treatment or later and/or shrunken or no longer detectable tumors.
* The lowest PSA level reached after treatment start.
Doctors keep track of all medical problems (also called adverse events) that participants have during the study, even if they do not think that they might be related to the study treatment.
Anticancer activity is measured using cancer imaging techniques and change in blood level of a protein called PSA. PSA is made by normal and by cancerous cells in the body. The PSA level is taken as a marker for prostate cancer development and is usually elevated in participants with mCRPC.
In addition, researchers want to find out how 225Ac-pelgi moves into, through and out of the body.
The study will have two parts. The first part, called dose escalation, is done to find the most appropriate dose and schedule that can be given in the second part of the study. For this, each participant will receive one of the predefined increasing doses of 225Ac-pelgi as an infusion into the vein. All participants in part 2, called dose expansion, will receive the most appropriate dose and schedule identified from the first part of the study. More than one dose level or schedule from part 1 may be tested. Both the participants and the study team know what treatment the participants will take.
Participants in this study will take the study treatment 225Ac-pelgi once in a period of 6 weeks called a cycle. Each participant will have 4 of these treatment cycles, if the participant benefits from the treatment.
Each participant will be in the study for up to nearly six years, including a first test (screening) phase of a maximum of 30 days, up to 12 months of treatment depending on the participant's benefit, and a follow-up phase of 60 months after the end of treatment. The following visits to the study site are planned: 2 during the screening phase, 8 in the first treatment cycle, 7 in subsequent cycles, and a visit 6 to 12 weeks after the last dose. In the following 12 months, visits are planned every 6 weeks and during the next 48 months phone calls or clinic visits are planned approximately every 12 weeks.
In addition, a sub study during the dose escalation part will gather information on the distribution of the study treatment in the body, the proportion that binds to the cancer cells, and the resulting radiation at the tumor site.
During the study, the study team will:
* Do physical examinations
* Check vital signs such as blood pressure, heart rate, and body temperature
* Take blood, and urine samples
* Examine heart health using echocardiogram and electrocardiogram (ECG)
* Take tumor samples
* Track 225Ac-pelgi in the body using gamma imaging (generally available at all study sites)
* Check the tumor status using PET (positron emission tomography), CT (computed tomography) or MRI (magnetic resonance imaging) and bone scan
* Ask questions about the impact of the disease on the participants' wellbeing and activities of daily life (Eastern Cooperative Oncology Group Performance status (ECOG PS)). Read Less
Gender:
MALE
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: City of Hope - Duarte Cancer Center, Duarte, California +30 locations
City of Hope - Duarte Cancer Center, Duarte, California
University of Minnesota Medical Center, Minneapolis, Minnesota
Mount Sinai Beth Israel - Nuclear Medicine / Radiology, New York, New York
University of Pittsburg Medical Center, Pittsburgh, Pennsylvania
University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas
Utah Cancer Specialists (UCS) (Intermountain Hematology - Oncology Associates) - UCS Cancer Center, Salt Lake City, Utah
Cross Cancer Institute, Clinical Trials Unit, Edmonton, Alberta
BC Cancer - Vancouver Site, Vancouver, British Columbia
Juravinski Cancer Centre - Clinical Trials Department, Hamilton, Ontario
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto, Ontario
Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopi, Montreal, Quebec
McGill University Health Centre (MUHC) - Research Institute (RI) - McConnell Centre for Innovative Medicine (CIM), Montreal, Quebec
Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hopital Fleurimont, Sherbrooke, Not set
Kuopio University Hospital, Kuopio, Pohjois-Savo
HUS, Meilahden sairaala, Helsinki, Uusimaa
Docrates Mehiläinen Syöpäsairaala, Helsinki, Uusimaa
Tampere University Hospital, Tampere, Not set
CRST Clinical Research Services Turku, Turku, Not set
Istituto Europeo di Oncologia s.r.l - Medicina Nucleare, Milano, Not set
IRCCS Istituto Nazionale Tumori Fondazione Pascale - S. C. Medicina Nucleare e Terapia Metabolica, Napoli, Not set
Universitair Medisch Centrum Groningen, Groningen, Not set
Erasmus Medisch Centrum, Rotterdam, Not set
Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH, Göteborg, Not set
Skånes Universitetssjukhus Lund - Onkologens kliniska forskningsenhet, Lund, Not set
Karolinska Universitetssjukhuset - Fas I-enheten Solna CKC, Stockholm, Not set
Akademiska Sjukhuset - Fas-I-enheten, Uppsala, Not set
Kantonsspital Baden, Baden, Aargau
Cambridge University Hospitals NHS Foundation Trust | Addenbrookes Hospital - Clinical Research Centre, Cambridge, Cambridgeshire
Royal Marsden NHS Trust (Surrey), Sutton, Surrey
University College London Hospitals NHS Foundation Trust, London, Not set
The Newcastle upon Tyne Hospitals NHS Foundation Trust | Freeman Hospital - Cancer Trials Research Centre, Newcastle upon Tyne, Not set
Conditions: Metastatic Castration-resistant Prostate Cancer
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Recruiting
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Research Site, Tucson, Arizona +290 locations
Research Site, Tucson, Arizona
Research Site, Springdale, Arkansas
Research Site, Beverly Hills, California
Research Site, Glendale, California
Research Site, Los Alamitos, California
Research Site, Redlands, California
Research Site, San Francisco, California
Research Site, Walnut Creek, California
Research Site, West Haven, Connecticut
Research Site, Newark, Delaware
Research Site, Bay Pines, Florida
Research Site, Fort Lauderdale, Florida
Research Site, Gainesville, Florida
Research Site, Gainesville, Florida
Research Site, Jacksonville, Florida
Research Site, Athens, Georgia
Research Site, Atlanta, Georgia
Research Site, Boise, Idaho
Research Site, Chicago, Illinois
Research Site, Decatur, Illinois
Research Site, Hinsdale, Illinois
Research Site, Quincy, Illinois
Research Site, Waterloo, Iowa
Research Site, Lexington, Kentucky
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Louisville, Kentucky
Research Site, Alexandria, Louisiana
Research Site, Baton Rouge, Louisiana
Research Site, Covington, Louisiana
Research Site, Shreveport, Louisiana
Research Site, Shreveport, Louisiana
Research Site, South Portland, Maine
Research Site, Baltimore, Maryland
Research Site, Bethesda, Maryland
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Duluth, Minnesota
Research Site, Rochester, Minnesota
Research Site, Bridgeton, Missouri
Research Site, Columbia, Missouri
Research Site, Kansas City, Missouri
Research Site, Lincoln, Nebraska
Research Site, Camden, New Jersey
Research Site, Buffalo, New York
Research Site, East Syracuse, New York
Research Site, Westbury, New York
Research Site, Cincinnati, Ohio
Research Site, Bend, Oregon
Research Site, Medford, Oregon
Research Site, Salem, Oregon
Research Site, Hershey, Pennsylvania
Research Site, York, Pennsylvania
Research Site, Sioux Falls, South Dakota
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Kingwood, Texas
Research Site, Lubbock, Texas
Research Site, Round Rock, Texas
Research Site, Fairfax, Virginia
Research Site, Fredericksburg, Virginia
Research Site, Olympia, Washington
Research Site, Seattle, Washington
Research Site, Silverdale, Washington
Research Site, Spokane, Washington
Research Site, Tacoma, Washington
Research Site, Wenatchee, Washington
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, La Plata, Not set
Research Site, Pilar, Not set
Research Site, Rosario, Not set
Research Site, Darlinghurst, Not set
Research Site, Hyde Park, Not set
Research Site, Southport, Not set
Research Site, Wollongong, Not set
Research Site, Innsbruck, Not set
Research Site, Krems, Not set
Research Site, Rankweil, Not set
Research Site, Wien, Not set
Research Site, Wien, Not set
Research Site, Anderlecht, Not set
Research Site, Brussels, Not set
Research Site, Charleroi, Not set
Research Site, Kortrijk, Not set
Research Site, Ottignies, Not set
Research Site, Sint-Niklaas, Not set
Research Site, Barretos, Not set
Research Site, Florianópolis, Not set
Research Site, Ijuí, Not set
Research Site, Londrina, Not set
Research Site, Porto Alegre, Not set
Research Site, Salvador, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Taubaté, Not set
Research Site, Saint John, New Brunswick
Research Site, Sydney, Nova Scotia
Research Site, Hamilton, Ontario
Research Site, Sault Ste. Marie, Ontario
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changchun, Not set
Research Site, Changde, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Dalian, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Linyi, Not set
Research Site, Nanchang, Not set
Research Site, Ningbo, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Wenzhou, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Yangzhou, Not set
Research Site, Yueyang, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Avignon, Not set
Research Site, La Rochelle Cedex, Not set
Research Site, Lyon, Not set
Research Site, Nimes, Not set
Research Site, Rennes, Not set
Research Site, Strasbourg Cedex, Not set
Research Site, Suresnes, Not set
Research Site, Toulon Cedex 9, Not set
Research Site, Bad Berka, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Esslingen, Not set
Research Site, Frankfurt, Not set
Research Site, Gauting, Not set
Research Site, Gießen, Not set
Research Site, Großhansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Heidelberg, Not set
Research Site, Hemer, Not set
Research Site, Homburg, Not set
Research Site, Kassel, Not set
Research Site, Kiel, Not set
Research Site, Krefeld, Not set
Research Site, Köln, Not set
Research Site, Minden, Not set
Research Site, Moers, Not set
Research Site, München, Not set
Research Site, Regensburg, Not set
Research Site, Würzburg, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Gyöngyös, Not set
Research Site, Győr, Not set
Research Site, Pécs, Not set
Research Site, Székesfehérvár, Not set
Research Site, Törökbálint, Not set
Research Site, Calicut, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Madurai, Not set
Research Site, Mumbai, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, Pondicherry, Not set
Research Site, Surat, Not set
Research Site, Varanasi, Not set
Research Site, Firenze, Not set
Research Site, Monza, Not set
Research Site, Orbassano, Not set
Research Site, Padova, Not set
Research Site, Peschiera Del Garda, Not set
Research Site, Roma, Not set
Research Site, Amagasaki-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kawagoe-shi, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Matsusaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama, Not set
Research Site, Ota-shi, Not set
Research Site, Saitama-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Cheongju-si, Not set
Research Site, Incheon, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Suwon-si, Not set
Research Site, George Town, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Alkmaar, Not set
Research Site, Ede, Not set
Research Site, Groningen, Not set
Research Site, Leidschendam, Not set
Research Site, Veldhoven, Not set
Research Site, Zwolle, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Biała Podlaska, Not set
Research Site, Białystok, Not set
Research Site, Bydgoszcz, Not set
Research Site, Bystra, Not set
Research Site, Poznań, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, San Juan, Not set
Research Site, San Juan, Not set
Research Site, Barcelona, Not set
Research Site, Las Palmas de Gran Canaria, Not set
Research Site, Lérida, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Sevilla, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Dusit, Not set
Research Site, Nakhon Ratchasima, Not set
Research Site, Songkla, Not set
Research Site, Antalya, Not set
Research Site, İstanbul, Not set
Research Site, Yenimahalle, Not set
Research Site, Aberdeen, Not set
Research Site, Cambridge, Not set
Research Site, Edinburgh, Not set
Research Site, Exeter, Not set
Research Site, Greater London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Newcastle upon Tyne, Not set
Research Site, Preston, Not set
Research Site, Can Tho, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh City, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Vinh, Not set
Conditions: Non-small Cell Lung Cancer
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Recruiting
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-APP administered by intrathecal (IT) injection in adult patients with early-onset Alzheimer's Disease (EOAD). Maximum treatment duration for Part A: single dose. Maximum treatment duration for Part B: 12 months.
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-APP administered by intrathecal (IT) injection in adult patients with early-onset Alzheimer's Disease (EOAD). Maximum treatment duration for Part A: single dose. Maximum treatment duration for Part B: 12 months. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Clinical Trial Site, San Diego, California +7 locations
Clinical Trial Site, San Diego, California
Clinical Trial Site, San Diego, California
Clinical Trial Site, Indianapolis, Indiana
Clinical Trial Site, Toronto, Ontario
Clinical Trial Site, Montréal, Quebec
Clinical Trial Site, Amsterdam, Not set
Clinical Trial Site, London, Not set
Clinical Trial Site, Sheffield, Not set
Conditions: Early-Onset Alzheimer Disease
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Recruiting
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment.
All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone fo... Read More
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment.
All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone for an additional 44 weeks.
Each participant will be followed up for at least 26 weeks after the last dose of vedolizumab. Read Less
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/24/2025
Locations: Digestive Health Specialsits, Dothan, Alabama +49 locations
Digestive Health Specialsits, Dothan, Alabama
GI Alliance Sun City, Sun City, Arizona
Cedars-Sinai Medical Center, Los Angeles, California
Hoag Hospital Newport Beach, Newport Beach, California
Endoscopic Research Inc, Orlando, Florida
Alliance Clinical Research of Tampa, LLC, Tampa, Florida
Gastroenterology Consultants, P.C., Roswell, Georgia
University of Chicago Medicine, Chicago, Illinois
GI Alliance - Illinois Gastroenterology Group - Glenview, Glenview, Illinois
GI Alliance - Illinois Gastroenterology Group LLC - Gurnee, Gurnee, Illinois
University of Kansas Medical Center, Kansas City, Kansas
University of Louisville, Louisville, Kentucky
GI Alliance, Metairie, Louisiana
Tulane University, New Orleans, Louisiana
Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase, Maryland
Huron Gastroenterology Associates, P.C., Ypsilanti, Michigan
MNGI Digestive Health, PA, Plymouth, Minnesota
Mid-America Gastro-Intestinal Consultants, Kansas City, Missouri
BVL Clinical Research, Liberty, Missouri
Washington University School of Medicine, Saint Louis, Missouri
NYU Langone Health, New York, New York
Weill Cornell Medical College- New York Presbyterian Hospital, New York, New York
Digestive Health Partners - Asheville Gastroenterology Associate, Asheville, North Carolina
University of North Carolina, Chapel Hill, North Carolina
University of Cincinnati, Cincinnati, Ohio
Ohio Gastroenterology group, Inc., Columbus, Ohio
Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake, Ohio
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Allegheny Health Network, Wexford, Pennsylvania
University Gastroenterology, Providence, Rhode Island
Rapid City Medical Center, LLP, Rapid City, South Dakota
GI Alliance - Digestive Health Associates of Texas, Dallas, Texas
The University of Texas Health Science Center at Houston, Houston, Texas
GI Alliance - Mansfield, Mansfield, Texas
Gastroenterology Research of San Antonio, LLC, San Antonio, Texas
Texas Digestive Disease Consultants (TDDC), Southlake, Southlake, Texas
Tyler Research Institute, LLC, Tyler, Texas
GI Alliance - Webster, Webster, Texas
University of Utah Health, Salt Lake City, Utah
Washington Gastroenterology- GIA, Bellevue, Washington
Washington Gastroenterology- GIA, Tacoma, Washington
Barrie GI Associates Inc., Barrie, Ontario
London Health Sciences Centre, London, Ontario
West GTA Endoscopy Inc., Mississauga, Ontario
Viable Clinical Research - North Bay, North Bay, Ontario
Toronto Immune and Digestive Health Institute Inc. (TIDHI), North York, Ontario
ABP Research Services Corp., Oakville, Ontario
Taunton Surgical Centre, Oshawa, Ontario
Toronto Digestive Disease Associates (TDDA) Specialty Research, Vaughan, Ontario
McGill University Health Centre Montreal General Hospital, Montreal, Quebec
Conditions: Ulcerative Colitis
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Local Institution - 0136, Augusta, Georgia +143 locations
Local Institution - 0136, Augusta, Georgia
Local Institution - 0221, Des Moines, Iowa
Massachusetts General Hospital, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Local Institution - 0217, Brooklyn, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York
Laura and Isaac Perlmutter Cancer Center, New York, New York
Local Institution - 0127, Syracuse, New York
Local Institution - 0214, Tacoma, Washington
Local Institution - 0061, Milwaukee, Wisconsin
Local Institution - 0092, Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires
Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0106, Buenos Aires, Not set
Local Institution - 0207, Buenos Aires, Not set
Instituto Oncológico de Córdoba, Córdoba, Not set
Local Institution - 0041, Wien, Not set
Hospital Luxemburgo, Belo Horizonte, Minas Gerais
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Hospital Sírio Libanês, Sao Paulo, São Paulo
Hospital Paulistano, Sao Paulo, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo
Hospital São Lucas de Copacabana, Rio de Janeiro, Not set
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Not set
Local Institution - 0002, Toronto, Ontario
Local Institution - 0123, Trois-Rivières, Quebec
Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago
Oncocentro Apys, Viña del Mar, Valparaíso
Local Institution - 0168, Beijing, Beijing
Local Institution - 0185, Chongqing, Chongqing
Local Institution - 0192, Fuzhou, Fujian
Local Institution - 0169, Xiamen, Fujian
Local Institution - 0180, Guangzhou, Guangdong
Local Institution - 0194, Nanning, Guangxi
Local Institution - 0171, Harbin, Heilongjiang
Local Institution - 0166, Zhengzhou, Henan
Local Institution - 0181, Wuhan Shi, Hubei
Local Institution - 0203, Wuhan, Hubei
Local Institution - 0184, Changsha, Hunan
Local Institution - 0165, Changsha, Hunan
Local Institution - 0193, Nanjing, Jiangsu
Local Institution - 0202, Nanchang, Jiangxi
Local Institution - 0178, Changchun, Jilin
Local Institution - 0183, Xi'an, Shaanxi
Local Institution - 0186, Jinan, Shandong
Local Institution - 0205, Linyi, Shandong
Local Institution - 0164, Shanghai, Shanghai
Local Institution - 0179, Shanghai, Shanghai
Local Institution - 0170, Chengdu, Sichuan
Local Institution - 0177, Chengdu, Sichuan
Local Institution - 0204, Kunming, Yunnan
Local Institution - 0206, Hangzhou, Zhejiang
Local Institution - 0175, Hangzhou, Zhejiang
Nouvel Hôpital Civil (NHC), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Centre Georges François Leclerc, Dijon, Côte-d'Or
CHU Charles Nicolle, Rouen, Haute-Normandie
Chu Grenoble Alpes, La Tronche, Isère
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique
Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Klinikum Esslingen, Esslingen, Baden-Württemberg
Klinikum Würzburg Mitte, Wuerzburg, Bayern
Pius Hospital Oldenburg, Oldenburg, Niedersachsen
Evangelische Lungenklinik Berlin, Berlin, Not set
Local Institution - 0035, Dresden, Not set
Asklepios Klinik Gauting GmbH, Gauting, Not set
Lungenfachklinik Immenhausen, Immenhausen, Not set
Universitaetsklinikum Koeln, Köln, Not set
Marienhaus Klinikum Mainz, Mainz, Not set
University Hospital of Patras, Patras, Achaḯa
Thoracic General Hospital of Athens "I Sotiria", Athens, Attikí
Attikon General University Hospital, Chaidari, Attikí
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
Országos Korányi Pulmonológiai Intézet, Budapest, Not set
All India Institute of Medical Sciences, New Delhi, Delhi
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi
Hemato Oncology Clinic, Ahmedabad, Gujarat
HCG Aastha Cancer Centre, Ahmedabad, Gujarat
Local Institution - 0117, Gurgaon, Haryana
Artemis hospital, Gurugram, Haryana
Manipal Hospitals, Bengaluru, Karnataka
Local Institution - 0219, Thiruvananthapuram, Kerala
Local Institution - 0065, Mumbai, Maharashtra
Local Institution - 0048, Mumbai, Maharashtra
Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra
Sahyadri Super Speciality Hospital, Pune, Maharashtra
Local Institution - 0220, Hyderabad, Telangana
Cro-Irccs, Aviano, Friuli-Venezia Giulia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia
A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli
Istituto Nazionale Tumori Regina Elena, Rome, Roma
Nagoya University Hospital, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime
Hokkaido University Hospital, Sapporo, Hokkaido
Kanagawa cancer center, Yokohama, Kanagawa
Sendai Kosei Hospital, Sendai, Miyagi
Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Osaka City General Hospital, Osaka, Not set
Osaka International Cancer Institute, Osaka, Not set
Tokyo Metropolitan Police Hospital, Tokyo, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0223, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0237, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0222, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0226, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0224, Putrajaya, Wilayah Persekutuan Kuala Lumpur
Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland
Local Institution - 0215, Groningen, Not set
Local Institution - 0187, Lublin, Lubelskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie, Olsztyn, Warmińsko-mazurskie
SC Memorial Healthcare International SRL, Bucharest, București
Institutul Oncologic Bucuresti, Bucharest, București
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
Institutul Oncologic Cluj, Cluj, Not set
S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set
CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Kantonspital Baden, Baden, Aargau
Ankara Bilkent Şehir Hastanesi, Yenimahalle, Ankara
Adana Medical Park Seyhan Hastanesi, Adana, Not set
Sbü Gülhane Eğitim Ve Araştirma Hastanesi, Ankara, Not set
Medipol Mega Universite Hastanesi, Istanbul, Not set
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Istanbul, Not set
VM Medical Park Pendik Hospital, Istanbul, Not set
Sakarya Training and Research Hospital, Sakarya, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
241 - 252 of 3905